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 Activity of the Ryanodine Receptor (RyR2) (aka cardiac Ca2+ release channel) 
plays a pivotal role in contraction of the heart.  S-adenosyl-l-methionine (SAM) is a 
biological methyl group donor that has close structural similarity to ATP, an important 
physiological regulator of RyR2. This work provides evidence that SAM can act as a 
RyR2 regulatory ligand in a manner independent from its recognized role as a biological 
methyl group donor.  RyR2 activation appears to arise from the direct interaction of 
SAM, via its adenosyl moiety, with the RyR2 adenine nucleotide binding sites. Because 
uncertainty remains regarding the structural motifs involved in RyR2 modulation by ATP 
and its metabolites, this finding has important implications for clarifying the structural 
basis of ATP regulation of RyR2. 
 During the course of this project, direct measurements of single RyR2 activity 
revealed that SAM has distinct effects on RyR2 conductance.  From the cytosolic side of 
the channel, SAM produced a single clearly resolved subconductance state.  The effects 
of SAM on channel conductance were dependent on SAM concentration and membrane 
holding potential.  A second goal of this work was to distinguish between the two 
possible mechanisms by which SAM could reduce RyR2 conductance: i) SAM 
interfering directly with ion permeation via binding within the conduction pathway (pore 
block), or ii) SAM binding a regulatory (or allosteric) site thereby stabilizing or inducing 
a reduced conductance conformation of the channel. It was determined that SAM does 
not directly interact with the RyR2 conduction pathway.   
 xiv
 To account for these observations an allosteric model for the effect of SAM on 
RyR2 conductance is proposed.  According to this model, SAM binding stabilizes an 
inherent RyR2 subconductance conformation.  The voltage dependence of the SAM 
related subconductance state is accounted for by direct effects of voltage on channel 
conformation which indirectly alter the affinity of RyR2 for SAM.  Patterns in the 
transitions between RyR2 conductance states in the presence of SAM may provide 
insight into the structure-activity relationship of RyR2 which can aid in the development 










 1.1 Ryanodine Receptors  
 
1.1.1. Brief History:Elucidating the role of RyR in excitation-contraction coupling 
 In 1965 Alexander Sandow defined excitation-contraction coupling as “the 
function of the muscle fiber in which an electrical depolarization of the plasma 
membrane initiates a sequence of reactions that causes mechanical activation of the 
contractile myofibrils lying within the membrane”(1).  The Ryanodine Receptor (RyR) is 
an ion channel most renowned for its critical role in this E-C coupling process.  In the 
1960s there was strong evidence to suggest that Ca2+ ions served as the direct chemical 
activator of muscle contraction.  For example, Sidney Ringer found that isolated rat 
hearts beat perfectly when bathed in medium made with tap water, but when using 
distilled water, supplementation with Ca2+ ions was required to maintain contraction (2).  
Later, Heilbrunn and Wiercinski showed that the addition of Ca2+ to the cut ends of frog 
skeletal muscle fibers elicited contraction, and that of the various physiologically relevant 
ions applied directly to the cytoplasm, only Ca2+ elicited contraction (3, 4).  However,  
‘the sequence of reactions’ linking depolarization of the plasma membrane to a rise in 
cytoplasmic Ca2+ were poorly defined; the ryanodine receptor had not yet been 
discovered.   
 Striated muscle has an internal membrane system known as the sarcoplasmic 
reticulum (SR), which functions as an intracellular compartment for Ca2+ storage, and a 
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system of transverse tubules (T-tubules) which are invaginations of the plasma 
membrane.  The SR consists of two distinct domains: the longitudinal SR and the 
junctional SR.  The longitudinal SR surrounds the myofibrils as a network of 
interconnected tubules which coalesce at their ends into a single sac called terminal 
cisternae (i.e. junctional SR) (5).  In 1962 Ebashi showed that SR extracted from muscle 
is able to accumulate Ca2+ from its external medium against very high electrochemical 
gradients and suggested a role for SR Ca2+ in the regulation of muscular contraction (6).  
Indeed, subsequent research would later reveal that the close apposition of the SR and T- 
tubule membranes establish the structural framework for E-C coupling in skeletal and 
cardiac muscle.  
 An early clue towards unraveling the E-C coupling mystery came in the 1980s 
through the work of Clara Franzini-Armstrong and colleagues.  Using electron 
microscopy (EM), images of sectioned muscle revealed electron dense particles located at 
the junctions between the SR and T-tubules.  These structures were given the name 
“foot” protein (7, 8).  EM images also revealed that the junctional domains of the T-
tubules were occupied by so called tetrads, each consisting of 4 intrinsic membrane 
particles (7).  The positioning of tetrads in the junctional domain of T- tubules, and the 
feet in the SR suggested that these two proteins directly or indirectly interact possibly 
forming the link between excitation and contraction (i.e. electrical signals at the plasma 
membrane and the release of SR Ca2+.) 
 Ryanodine proved invaluable in the identification and characterization of the 
junctional foot protein seen in EM images.  Ryanodine, a natural plant alkaloid, was 
know to be toxic to animals, causing irreversible muscle contractions resulting in death 
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(9). At the time, it was not known that ryanodine binds with high specificity and affinity 
to the SR Ca2+ release channel (RyR) when it is open, thereby locking the channel an 
“open state” so that Ca2+ is not reaccumulated into the SR and the muscle cannot relax.  
Fleischer and colleagues showed that ryanodine blocked Ca2+ release from the SR, and 
direct binding studies with [3H]ryanodine localized the receptors to the junctional region 
(terminal cisternae) of the SR (10).  These findings supported previously accumulated 
evidence that Ca2+ release is localized to the junctional domain of the SR.   EM images of 
the protein revealed a complex with fourfold symmetry having the overall dimensions 
and morphology consistent with the previously identified foot structure (11, 12), and 
when reconstituted into artificial bilayers the protein formed a high conductance Ca2+ 
channel (13, 14).   
 The present understanding of E-C coupling entails a critical interaction between 
the RyR SR Ca2+ release channel, and a voltage gated L-type Ca2+ channel, Cav1.1 (aka. 
dihydropyridine receptor, DHPR) within the T tubule membrane (previously seen in EM 
images as tetrads in the junctional region of T- tubules).   The functional coupling 
between DHPR and RyR provides the link between depolarization of the surface 
membrane and release of SR Ca2+.  The mechanistic details of E-C coupling differ 
between skeletal and cardiac muscle.  In skeletal muscle, a voltage induced 
conformational change in DHPR is transmitted to RyR via a physical interaction thereby 
activating Ca2+ release from the SR.  In this system DHPR acts primarily as a voltage 
sensor rather than a Ca2+ channel; the influx of Ca2+ is not required.  In cardiac muscle, 
E-C coupling occurs through a process of Ca2+ induced Ca2+ release (CICR) whereby the 
influx of external Ca2+ via the DHPR serves as the RyR activation signal. Thus the DHPR 
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and RyR do not physically interact.  The sensitivity of Ca2+ induced activation of RyR 
forms the basis of CICR regulation in the heart.   
 
1.1.2  Isoforms  
There are three mammalian isoforms of the Ryanodine receptor encoded by three 
different genes; they are referred to as RyR1, RyR2, and RyR3.  The isoforms exhibit 
~70% overall sequence identity.  The three isoforms differ in their tissue distribution.  
RyR1 and RyR2 are predominantly expressed in skeletal and cardiac muscle, respectively 
(15, 16), while RyR3 has a wide tissue distribution.    
 
1.1.3. Structure and macromolecular complex 
 Two classes of intracellular ion channels have evolved to release Ca2+ from 
intracellular stores, the inositol (1,4,5)-trisphosphate receptor (IP3R), and RyR.  Both 
Ip3R and RyR play important roles in fluctuations in intracellular Ca2+ concentrations 
which underlie a wide variety of physiological processes including cell division, memory 
and learning, and hormonal secretion.  However, RyR has the singular claim to fame as 
the SR Ca2+ release channel in skeletal and cardiac muscle; a critical mediator of E-C 
coupling.  RyRs were first observed as the 'foot' structures that bridge the approximate 12 
nm (120Å) gap separating the T-tubule and SR membranes in cardiac and skeletal muscle 
(17).  RyR is the largest of all ion channels and size is one of the greatest challenges 
faced in the elucidation of protein structure.  
RyRs are high molecular weight homotetramers consisting of a C-terminal SR 
membrane spanning domain which forms an ion conduction pathway approximately 7 
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nM in length and 8 nM in diameter (12).  The channel’s large N-terminal cytoplasmic 
domain has the approximate dimensions 29x29x12 nM (12, 15).  The quatrefoil structure 
of RyR arises from the symmetrical arrangement of four identical subunits of 
approximately 5,000 amino acids, or 560 kDa, each contributing to the formation of a 
single central ion conduction pathway.  The tetrameric channel encompasses 
approximately 20,000 amino acids.  Although the exact number remains to be 
determined, 6-8 transmembrane alpha helices are believed to form the channel’s central 
pore.  The pore may function in a manner analogous to the opening and closing of the iris 
of a camera.  The pore dimensions are approximate, 2-3Å in width with a voltage drop of  
10.4 Å in length (18).  
Each RyR tetramer exists in its native membrane in complex with several 
accessory proteins.  The best known RyR-interacting proteins are calmodulin (CaM), 
which tonically inhibits RyR2 activity and produces biphasic effects on RyR1(19, 20), 
FK506 binding proteins (FKBPs) which stabilize RyR in its closed state (21, 22), and the 
triadin-junctin-calsequestrin complex which senses luminal Ca2+ and modulates RyR 
activity by acting either as a Ca2+ reservoir or as a direct channel ligand (for review see 
(23).  Additionally, anchoring sites for proteins involved in posttranslational RyR 
regulation have been identified.  Protein kinase A (PKA), calmodulin-dependent protein 
kinase (CaMK)II, protein phosphatase (PP)1, and the cAMP-specific phosphodiesterase 
(PDE)4D3 are among the well characterized proteins which are critical to the 
physiological and pathological regulation of RyR (15, 22, 24).  In addition to 
phosphorylation (18), a role for oxidation and nitration in RyR modification has been 
established (25, 26).  
 5
1.1.4. Functional assays 
 
1.1.4.1. Ryanodine Binding 
The purification of the Ryanodine Receptor (RyR) from skeletal and cardiac SR was 
made possible through the use of the plant alkaloid ryanodine, which binds to RyR with 
high specificity and affinity (nanomolar range).  Ryanodine binds channels only in the 
open state, a property which has made [3H]ryanodine binding a useful functional probe of 
the opening of RyRs by other ligands (27, 28).  Effectors which activate the channel 
increase the rate of [3H]ryanodine binding, while the rate of binding is decreased upon 
exposure of RyRs to channel inhibitors. Ryanodine binding is a straightforward assay that 
correlates well with RyR activation levels.  Therefore, the [3H]ryanodine binding assay is 
a sensitive and efficient method for investigating the function of a large number of RyR 
channels. 
 
1.1.4.2. Reconstitution into planar lipid bilayers 
Direct measurements of channel activity can provide mechanistic insights that would be 
otherwise undetected by [3H]ryanodine binding.  Because RyRs are located in the 
membrane of intracellular organelles, they are not directly accessible to patch pipettes, 
thus single RyRs are not easily studied by traditional patch techniques. Instead SR 
vesicles or purified RyRs are incorporated into an artificial lipid bilayer separating two 
ionic solutions. This setup allows considerable flexibility in manipulating experimental 
conditions.   
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 The method used to form lipid bilayers is a modification of the film drainage 
method originally developed by Mueller et al (29).  Lipids resuspended in a hydrophobic 
solvent such as n-decane are spread across a small aperture in a plastic septum producing 
a thin lipid film separating two fluid filled chambers.  Both bilayer formation and channel 
incorporation are spontaneous processes.  Ion channel protein is added to one side of the 
bilayer referred to as the cis (cytoplasmic) side because the channel will almost always 
incorporate with its large cytoplasmic domain exposed to the bath to which the protein 
was added.  The luminal (SR lumen) side of the channel will face the opposite (trans) 
bath.  Conditions which promote vesicle fusion include i) vigorous stirring of the cis bath 
(usually with a magnetic stirrer), ii) an osmotic gradient across the membrane (cis high), 
and iii) millimolar cis [Ca2+]. When SR vesicles are incorporated into the bilayer, cesium 
methanesulphonate (CsMS) is commonly used as the principal salt in the chamber 
solutions.  This is to prevent current signals from other ion channels from interfering with 
RyR recordings.  RyR is quite permeable to Cs+, whereas other ion channels in the SR do 
not conduct Cs+ or MS-.  Once a channel incorporates it is possible to determine the ion 
conductance of a single channel (unitary conductance) and to monitor its opening and 
closing (gating) by measuring the current through the membrane in response to an 
applied electrochemical gradient.   
 Single RyR channel current signals appear as stochastic jumps typically between 
two stationary current levels representative of the channel in a closed, non conducting 
state, and an open, maximum conducting state.  Less common intermediate current levels 
corresponding to subconductance states may also appear in RyR current records (see 
section 1.3.2).  Stationary current levels are identifiable as peaks in amplitude histograms.  
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The peak width and the area under each peak reflect respectively, background noise, and 
time spent at that current level.  Open probability (Po), an overall measure of channel 
activity, is determined from current records as the fraction of time the channel is in a 
conducting state.  An increase in Po can arise from either an increased lifetime of the 
open state or a decreased lifetime of the closed state, also referred to as frequency of 
channel opening.   
 
1.1.5. Biophysical properties 
 
1.1.5.1. Gating and kinetic analysis 
 Descriptions of channel gating are based upon mathematical models that assume 
the existence of one or more closed state(s) and one or more open state(s).  Figure 1A 
describes the kinetic behavior of a channel which can exist in only two states, open (O) 
and closed (C).   For this 2 state channel, the time spent in any state is given by the 
reciprocal of the sum of the rate constants for leaving that state.  Because the mean open 
time is 1/k-1 and the mean closed time is 1/k1, the rate constants can be obtained by 
measuring the mean open and closed times.  The opening and closing of a single channel 
is well modeled by a Markovian or memoryless process meaning the state transition 
probability does not depend on previous states. As a consequence, channel lifetimes 
(open and closed times) are distributed exponentially (Fig. 1 B).  With a single open (or 
closed) state as shown in Figure 1, the open (or closed) time distribution will follow a 
single exponential and the mean open (or closed) time will be given by the time constant 
of the distribution (i.e. τo or τc).  It is not uncommon for channels to have several 
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kinetically distinguishable open (or closed) states, thus channel lifetimes may be best 
described by the sum of multiple exponential functions.  In general the number of 
exponential components in the open (or closed) time distribution gives a lower estimate 
of the number of different states (i.e. channel conformations) associated with opening (or 
closing) events.   
 Analysis of single channel gating kinetics has provided insight into the 
mechanism underlying cytosolic Ca2+ activation of RyR.  In the presence of 10 µM 
cytosolic Ca2+ the majority of channel openings are ≥1 ms in duration (30).  The Ca2+-
induced increase in channel Po arises from an increase in the frequency of channel 
openings, in other words, the progressive increase in Po with increasing [Ca2+] is 
associated with a decrease in the duration of all closed dwell times (30).  This has been 
attributed to Ca2+ ions binding to and thereby decreasing the dwell time of individual 
closed states.  The behavior of RyR under physiological conditions has been well 
described by models which include two or three closed states and two open states (31).  
Using higher temporal resolution, up to three open and five closed states have been 
described for RyR (30).  Correlation analysis of successive lifetimes suggested at least 
two distinct pathways exist between open and closed states.  This finding lead to the 






Figure 1.  Kinetic analysis of single channel currents.  A. Kinetic behavior of a 
hypothetical channel which can exist in either an open (O) or closed (C) state, where k1 
and k-1 are the rate constants (in sec-1) for entering and leaving the open state, 
respectively.  B. For a channel with one open state, the open times will follow a single 
exponential distribution.  The time at which the number of events falls to 1/e of its 
















Figure 2.  Minimal Kinetic Scheme for Ca2+ Activation of RyR.  Ca2+ activated RyR2 has 
been described by a model which includes at least three closed states and two open states.  
This cyclical or branched gating scheme proposed by Ashley and Williams (1990) 
permits channel openings to two open states (O) from a single closed state (□).  Ca2+  (C) 
activation of RyR has been attributed to a Ca2+-induced decrease in the duration of closed 













1.1.5.2 Conductance and selectivity 
 Ion channels are highly permeable to some but not all ions.  The ion selectivity of 
a channel arises partially from the shape of the ions and the channel pore, and partially 
from energy changes that accompany ion permeation. The ryanodine receptor is a poorly 
selective channel which has a high conductance for group Ia monovalent cations (Li+, 
Na+, K+, Rb+, Cs+) and the alkaline earth divalent cations (Ba2+, Sr2+, Ca2+, Mg2+).   The 
channel has a unitary conductance of ~750 pS in symmetrical 250 mM K+ and ~150 pS in 
symmetrical Ca2+.  The channel’s large Ca2+ conductance was originally demonstrated in 
recordings of native RyR channels (13, 32).   Under bi-ionic conditions RyR is 
significantly more permeable to the alkaline earth divalent cations over K+, however, 
there is little difference in permeability among the individual divalent cations or among 
the group Ia monovalent cations.  Although the conductance of RyR for monovalent 
cations is higher than for Ca2+, divalent cations are selected for over monovalent cations 
by a factor of 5-7 under physiological conditions (33).   
 RyR has a linear current-voltage relationship under symmetrical ionic conditions 
with monovalent cations as the permeant ions.  With divalent cations as the permeant 
ions, the linear current-voltage relationship deviates slightly from ohmic behavior at high 
holding potentials.(34, 35).  The Eyring rate theory has been used to model the movement 
of ions through channel pores.  This theory conceptualizes the movement of ions as a 
series of jumps between binding sites thought of as energy minima or ‘wells’ separated 
by energy maxima or ‘peaks’.  Ion binding affinity depends on well depth and ion 
selectivity depends on differences in peak heights.  Although rate theory is an 
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oversimplification of the underlying complex microscopic events, it can provide insight 
into the mechanisms of ion permeation in channels.   
 Investigations of the ionic conductance and selectivity properties of RyR2 from 
sheep cardiac muscle suggest that ions move in a single file through the RyR2 pore (34, 
35). Conductance measurements in mixtures of K+-Na+ and K+-Li+ revealed no 
anomalous behavior as the mole fraction of the ions is varied, a finding consistent with 
single pore occupancy.  Furthermore, the lack of rectification in the single channel 
current-voltage relationship implies a symmetric energy profile about a central axis.  
However, results from blocking experiments with a series of small tetraalkyl ammonium 
(TAA) cations suggested multiple pore occupancy (at least two cation binding sites). 
These blocking experiments also indicated that the RyR pore is most narrow close to the 
luminal face of the protein (36).  A 4 barrier, 3 binding site model has been used to 
describe characteristics of ionic conductance in RyR2.  Specifically, this model proposed 
the existence of a centrally located (within voltage drop) high affinity divalent binding 
site to account for the discrimination between divalent and monovalent cations (33).   
 
1.1.6. RyR channel regulation 
 RyR is a Ca2+ gated channel.  The sensitivity of Ca2+ induced activation of RyR 
forms the basis of CICR regulation in the heart.  Several factors influence the sensitivity 
of RyR to activation by Ca2+.  Some of the best characterized RyR effectors include 
adenine nucleotides which activate the channel, and Mg2+ which has an inhibitory affect 
(18, 27).   
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 RyR channel modulators are typically classified according to their effect on 
channel activity.  Single channel current recordings provide the greatest mechanistic 
insight into the agonistic or antagonistic effects of RyR regulators.  The majority of 
effectors act primarily by altering the opening and closing of the ion conduction pathway 
(through an allosteric mechanism), for example by increasing or decreasing the channels 
sensitivity to activation by Ca2+.  Some compounds are known to block RyR (i.e. 
physically obstruct the movement of ions through the channel pore; see section 1.3).   
 
1.1.6.1. Ryanodine  
 Interaction of the plant alkaloid ryanodine with single RyR channels results in 
complex, concentration dependent modulation of channel conductance and gating.  
Ryanodine has three effects on channel activity.  Submicromolar concentrations have 
been reported to increase channel Po to the full conductance state (37).  The more 
consistent finding, however, is for the channel to enter one or more relatively long lived 
subconductance states (most commonly to 50% of the full conductance level) in the 
presence of submicromolar concentrations of ryanodine.  Micromolar or higher 
concentrations of ryanodine cause complete channel closure (38).  The first two of the 
described effects are consistent with reports of a high affinity  [3H]ryanodine binding site 
and the third effect is consistent with the low affinity [3H]ryanodine binding site/s (one or 
three low affinity sites have been suggested). The effects of ryanodine and several of its 
synthesized derivatives (ryanoids) on the K+ conduction of RyR2 have been examined 
extensively. Unlike the control open state, the open probability of the ryanoid modified 
subconductance state is voltage dependent.  The amplitude of the modified substate 
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induced by ryanoids varies, ranging from ~5 to 70% of the full conductance state (39).  
Although the molecular location of ryanodine binding sites remains unknown, a 
comparative molecular field analysis of the relationship between the structure of a group 
of ryanoids and their modulation of RyR conductance properties wase not consistent with 
a direct interaction of ryanodine with the ion permeation pathway.  An allosteric 
mechanism has been proposed whereby ligand-induced conformational changes in the 
RyR mediate the interactions between ryanoids and permeant cations (see discussion in 
section 1.4.1) (40). 
 
1.1.6.2. Calcium and Magnesium  
 RyR is a Ca2+ gated channel, thus functional assays of channel activity require 
Ca2+ in the medium in order for the channel to assume an open conformation. RyR 
displays a bell shaped Ca2+ activation/inactivation curve in the absence of other effectors.  
The biphasic regulation of RyR by cystolic Ca2+ is well characterized and has been 
demonstrated in SR vesicle Ca2+ efflux measurements, [3H]ryanodine binding assays, and 
single channel recordings (41).  RyRs are activated by Ca2+ within the µM range and 
inhibited by Ca2+ in the µM-mM range.  The basis for this biphasic Ca2+ dependence is 
postulated to result from two distinct Ca2+ binding sites on the RyR channel, a high 
affinity binding site which when occupied opens the channel, and a low affinity binding 
site whose occupancy closes the channel.  In single channel experiments, RyR has a Po 
close to 0 in resting cytosolic Ca2+ (0.1 μM cis side).  Micromolar concentrations of 
cytosolic Ca2+ cause near full activation of RyR, while millimolar concentrations have an 
inhibitory effect (42).  Cytosolic Ca2+ is required for activation of the cardiac ryanodine 
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receptor (RyR2) (43, 44), but alone is not sufficient for maximal channel activity (30, 31, 
45).  Po values for channels activated by cytosolic Ca2+ alone (up to 100 µM; roughly 
corresponding to maximum physiological [Ca2+]) rarely exceed 0.5.  RyR is also 
regulated by luminal Ca2+, however whether this results from Ca2+ binding a luminal site 
or by gaining access to a cytoplasmic site (or both) remains unresolved (46, 47).    
 Magnesium inhibits RyR by two distinct mechanisms. Magnesium competes with 
Ca2+ for the high affinity Ca2+ activation site, although with much lower affinity 
(approximately 1 mmol/L affinity vs. 1 μmol/L affinity for Ca2+).  Additionally, Mg2+ 
and Ca2+ share a common inhibitory mechanism; at millimolar concentrations they both 
bind to the low affinity Ca2+ inhibitory site on the channel (48).  
 
1.1.6.3. FK506 binding proteins 
 The family of FK506-binding proteins (FKBPs) bind the immunosuppressive 
drugs FK506 and rapamycin.  The FKBP family has more than 20 members; the 
individual proteins are named according to their molecular mass.  FKBP12/12.6 are 
tightly associated with RyRs in a stoichiometry of 1 per monomer (21).  FKBP 12.6 is 
present in lower concentrations than FKBP12 in both cardiac and skeletal muscle (49).  
Although it was originally thought that only FKBP12.6 associated with RyR2 (50), recent 
studies have shown that the two FKBP isoforms bind both RyR1 and RyR2 (51). Due to 
its higher tissue concentration, FKBP12 is the predominant form bound to RyR1.  The 
preferential interaction of FKBP12.6 with RyR2 results from the much higher affinity of 
RyR2 for FKBP12.6 compared to FKBP12 (49).  FKBPs may have a role in coordinating 
interactions among the four RyR subunits, possibly stabilizing the maximum unitary 
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single channel conductance level.  A controversial hypothesis, initially proposed by 
Andrew Marks, maintains that PKA mediated phosphorylation of RyR2 at serine 2808 
(RyR2-S2808) causes FKBP12.6 dissociation thereby increasing channel open 
probability by inducing a long lived subconductance state(21, 22).  According to this 
hypothesis, RyR2 hyperphosphorylation causes the elevated diastolic Ca2+ leak observed 
in heart failure (22).  However, central tenets of this hypothesis have not always been 
reproduced.  Several groups found that PKA phosphorylation of RyR2-S2808 neither 
caused FKBP12.6 dissociation nor significantly altered channel gating (52-55).  At least 
two groups have failed to detect any effects of FKBP12.6 dissociation on RyR2 activity 
(52, 56).   
 
1.1.6.4. Adenine nucleotides 
 Adenine nucleotides activate RyR2 in a concentration and Ca2+ dependent manner 
(57).  In resting cardiac muscle, the basal ATP concentration is approximately 5-6 mM 
(58).  This is sufficiently high for ATP to function as a principal cellular regulator of 
RyR2 (59).  ATP, and its metabolites increase specific [3H]ryanodine binding to RyR2 
and increase channel open probability (43, 57, 60, 61).  The efficacy of ATP and its 
metabolites follows the order ATP>ADP>AMP>adenine >adenosine (43, 62).  ATP 
almost fully activates RyR2 with half-activating concentration (EC50) in the high 
micromolar range in the presence of 10 µM cytosolic Ca2+ (43).  ATP and other adenine 
based compounds are thought to bind to a poorly characterized adenine nucleotide 
binding site.  The purine ring is important for agonist activity as the replacement of 
adenine with guanine destroys the ability of the nucleotide to modulate RyR (57).  
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However, the structural features of adenine based compounds which impart efficacy in 
activating RyR2 are unknown.  Comparative molecular field analysis studies 
investigating correlations between ligand structure and efficacy in activating RyR2 have 
attributed the high efficacy of ATP to its negatively charged phosphate groups.  This 
conclusion was based on the observation that decreasing the number of phosphate groups 
decreases the ability of adenine nucleotides to open the channel (61).   
 Questions also remain regarding the number and location of ATP binding sites on 
RyR.  Depending on isoform and species the consensus sequence for an ATP binding 
site, GXGXXG, occurs between three and six times in the RyR sequence.  A study 
investigating the direct effects of ATP of RyR2 gating showed that in the presence of 10 
μM Ca2+ half maximal activation of RyR2 occurred at 0.22 mM ATP, and maximal 
channel activation occurred at 2 mM ATP.  A hill coefficient of 1.5  for the ATP dose-
response curve indicates that at least two molecules of ATP bind to the channel to cause 
maximal activation (43).   By monitoring the direct binding of a spin-labeled ATP, 
another group showed that a total of eight nucleotide binding sites are located on RyR1 
(63).  Together the characteristics of RyR activation by ATP, and direct binding studies 
suggest the presence of two ATP sites per RyR monomer.   
 
1.2. Molecular recognition of ATP in proteins 
 Although there is no universal fingerprint for ATP binding in proteins, a number 
of signature motifs are involved in the binding of nucleotide phosphate groups and their 
associated metal ions.  The phosphate-binding loop (P-loop) or Walker A motif consists 
of a glycine rich sequence followed by a conserved lysine and a serine or threonine 
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(GXXXXGK[TS])(64). The conserved lysine is thought to be important for loop 
conformation and may interact directly with β and γ phosphates of ATP via hydrogen 
bonding, while the conserved serine/threonine is believed to coordinate associated Mg2+ 
ions.  This sequence typically forms a flexible loop between a β-strand and an α-helix, 
therefore, a prudent search for potential ATP binding sites would consider the structural 
context in which identified glycine rich motifs are located.  Not all ATP binding proteins 
contain a P-loop within their primary sequence; these include the E1/E2 type ATPases, 
actin, tubulin, and gylcolytic kinases.  
  Non-bonded intermolecular interactions are also important molecular 
determinants for recognition of the adenine moiety of ATP by proteins(65).  These 
interactions occur between the adenine base and its surrounding residues in binding 
pockets of adenylate-binding proteins.  The three most important interactions are 
hydrogen bonding (adenine base has the capacity to form five H-bonds), π-π stacking 
interactions between the adenine base and aromatic residues (Phe, Tyr, and Trp), and 
cation-π interactions between the adenine base and positively charged residues (Lys, and 
Arg).   
 The inositol (1,4,5)-trisphosphate receptor (IP3R) and the ryanodine receptor are 
members of the intracellular Ca2+ channel super family.  ATP regulates both RyRs and 
IP3Rs in a manner, which does not require hydrolysis.  The activity of all three IP3R 
channel isoforms is increased by  micromolar concentrations of ATP and decreased with 
millimolar concentrations(66).  Two putative adenine nucleotide binding sites designated 
ATPA and ATPB have been identified within the regulatory domain of the type 1 IP3R at 
residues 1773-1780 and 2016-2021 respectively (66).  The glycine rich motifs within 
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these segments are believed to underlie the stimulatory effect of ATP on the IP3R 
channel.  The ATPA site is unique to the type 1 IP3R, ATPB is conserved among all 3 
channel isoforms, and a third sequence (ATPC) is formed upon the removal of the S2 
splice site from the type 1 IP3R (67).  The inhibitory effect of ATP at higher 
concentrations has been attributed to its action as a competitive antagonist at the IP3 
binding site (68).   
 A sequence alignment of the mouse type 1 IP3R with either the human or mouse 
RyR2 was performed with protein BLAST.  Neither IP3R consensus adenine nucleotide-
binding motif (residues 1773-1780 or 2016-2021), however, was among the 5 or 6 
BLAST hits producing significant sequence alignments.  Electron-spin resonance (ESR) 
spectroscopy on RyR1 has been used to monitor the interaction of a spin-labeled ATP 
with the intact RyR1 protein.   These studies suggested that each RyR1 monomer has 2 
functionally distinct ATP binding sites (63).  Sequence analysis of RyR1 predicts at least 
eight adenine nucleotide consensus binding motifs (GXGXXG) (69); a number, which 
greatly exceeds the two binding sites per monomer suggested by ESR studies.  The 
GXGXXG motif is present within the residues 2-7, 699-704, 1195-1200, 2264-2269, 
2370-2375, 4449-4454, 4452-4457, and 4602-4607 in RyR1.  Brandt and colleagues 
identified a RyR1 peptide fragment photo-labeled with 8-azido[α-32P]ATP containing the 
amino acids 2370-2375 providing additional evidence that this sequence may be a 
functional ATP binding site(70).   Four additional sequences, amino acids 1081-1084, 
2935-2938, 3503-3506, and 3937-3940, conform to the consensus ATP-binding sites 
Y[GAST][VG][KTQSN] reported to bind the purine ring of ATP in the chaperone 
protein GroES.  This motif has been proposed to form potential ATP binding sites in 
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RyRs as neither ATP bound to this site in GroES, nor ATP which activates RyRs is 
hydrolysed (71).  Otsu and colleagues predicted only one putative GXGXXG consensus 
site in the rabbit RyR2 sequence, residues 2619-2652.  This sequence was predicted to be 
preceded by a beta strand and followed by an alpha helix.  An additional GXGXXG 
sequence was found but not considered as an acceptable ATP binding site due to its 
inappropriate structural context (72).   
 Presumably only a subset, if any of the predicted consensus motifs in RyR confer 
sensitivity to ATP, yet this remains to be established.  Interestingly, a recent study 
demonstrated that mutation of the ATPA and ATPB sites in IP3R did not eliminate the 
ability of ATP to activate the channel, while mutation of ATPB in the type 2 and type 3 
IP3R eliminated the enhancing effects of ATP on the type 2 but not type 3 channels (73).  
Furthermore, mutagenesis of two predicted ATP binding sequences, GXGXXG (amino 
acids 2370-2375 of RyR1), and YSGK (amino acids 3937-3940 of RyR1), which are 
conserved among all RyR isoforms, did not alter ATP induced increase in [3H]ryanodine 
binding to any of the RyR1 mutants.  Mutations in the GXGXXG motif did, however, 
reduce caffeine and 4-chloro-m-cresol sensitivity of RyR1 (69).  Therefore ATP 
regulation of ion channel activity may involve a novel mechanism, and/or sequence 
analysis may be an inaccurate means of predicting putative adenine nucleotide binding 
sites in ion channels. 
 
1.3. Multiple conductance states in ion channels 
 The simplest model for an ion channel has an open (conducting) and closed (non-
conducting) state (i.e. conformation).  Therefore traditionally, gaiting refers to transitions 
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between the one open and one closed state (Fig 1).  The RyR regulators Ca2+, Mg2+, and 
adenine nucleotides discussed above under RyR channel regulation are classified as 
gating modifiers.  Adenine nucleotides, for example, increase overall time spent in the 
open state by stabilizing and destabilizing the channel open and closed conformations, 
respectively.  However, measurements of single channel activity have shown that many 
types of ion channels exhibit multiple open (and closed) states, thus not conforming to a 
simple two state model.  Indeed, the number and variety of ion channels for which 
subconductance behavior has been described suggests that channel gating is a dynamic 
process which involves transitions among a multitude of protein conformations having 
different energy minima and maxima.  
 
1.3.1. Ion channels exhibit subconductance behavior 
 Subconductance states have been described for a variety of ion channels including 
the acetylcholine receptor channel from embryonic rat muscle (74), the voltage dependent 
K+ channel from Torpedo electroplax (75), the Ca2+ dependent K+ channel of rat muscle 
(76), the serotonin dependent K+ channels from Aplysia sensory neurons (77), and RyR. 
Both GABA- and glycine- activated chloride channels display a range of conductance 
states (78).  Additionally, rapid voltage dependent transitions between subconductance 
states have been reported for type 1 and type 3 IP3R channels in Xenopus oocyte nuclei 
(79, 80).  Together these observations lend support to the theory that, even in the absence 
of regulatory ligands, channel proteins adopt multiple conformations having distinct ion 
permeation properties.  
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1.3.2. Subconductance behavior in RyRs 
 Ryanodine receptors are in part characterized by their large unitary single channel 
conductance (~750 pS in symmetrical 250 mM K+ and ~150 pS in symmetrical Ca2+), 
however, less prevalent subconductance states have been observed, and are especially 
evident in purified channels (81).  Ahern and colleagues observed brief openings to 
multiple conductance states in rabbit skeletal muscle RyRs, and that openings to an 
inherent conductance level ~30% of the maximum single channel conductance were 
prolonged in the presence of the immunosuppressant FK506 (82).  Similar 
subconductance behavior has been reported by others (21, 22).  The loss of RyR 
accessory proteins during enrichment of SR fractions by sucrose-gradient centrifugation 
may contribute to the greater prevalence of subconductance states in purified channels.  
Generally speaking substates are rarely observed in RyR; however, regulation of their 
occurrence may have physiological significance.  For example the level of RyR 
phosphorylation has been shown to influence channel gating between multiple open 
conductance states (83).   
 
1.4. Mechanisms of channel ’block’: Classic pore block vs. allosteric mechanism 
 Several venoms, herbs, food poisons, and drugs are known to affect the 
excitability of cell membranes by acting on ion channel proteins (84).  By inhibiting the 
ionic current through channels these agents can decrease membrane excitability.  Small 
charged species such as metal and organic cations can reduce whole cell currents by 
interfering directly with ion permeation via binding within the conduction pathway (i.e. 
pore block).  An allosteric mechanism has also been proposed whereby the binding of a 
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molecule at a regulatory or allosteric site stabilizes closed or reduced conductance 
conformations of the channel, essentially casing the pore to block itself.  Nature exploits 
both mechanisms, and it can be difficult to distinguish then unambiguously.  Depending 
on the ion channel and the nature of the interacting molecule, various lines of evidence 
can provide insight into the mechanism (classical pore block or allosteric) underlying ion 
channel ‘block’.  Included among these are: voltage dependence, effect of driving force, 
kinetic analysis, site directed mutagenesis, and structural data.   
 
1.4.1. Voltage dependence 
 In 1973 Ann Woodhull proposed a pore block model to explain the voltage 
dependent reduction of Na+ channel current produced by internal hydrogen ions (85).  
Woodhull reasoned that because the H+ induced reduction of sodium channel currents 
was dependent on the potential across the nerve cell membrane, H+ ions may bind to a 
site located within the pore partway into the electric field across the channel.  The rate 
constants for H+ binding and unbinding would therefore be voltage dependent because 
the proton needs to move through the electric field to get to its binding site in the channel 
pore. 
 Inhibition of ionic current through a variety of ion channels, including RyR, is 
consistent with Woodhull’s theory of direct pore block.  Block of RyR by TEA+ was 
manifest as a smooth, voltage dependent reduction in single channel current amplitude.  
Calculations from the Woodhull model suggest a single TEA+ binding site is located in 
the channel pore approximately 90% into the electric field across the channel from the 
cytosolic side (36).  The large tetra alkyl ammonium cation tetra butyl ammonium 
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(TBA+), the charged local anesthetic lidocaine, and two quaternary amines (QX572 and 
QX314) also reduced RyR channel conductance via a direct interaction with the 
permeation pathway.   From the cytosolic side TBA+ induced rapid current fluctuations 
between the maximum single channel conductance level and a low amplitude (~21% of 
maximum conductance) subconductance state.  This blocking phenomenon was 
dependent on TBA+ concentration, and only observed at positive membrane potentials 
(which promote cis to trans ion fluxes), and prevalence of the TBA+ related 
subconductance state increased as the potential across the channel is made increasingly 
positive(86).  Lidocaine, QX572, and QX314 likewise blocked only from the cystolic 
face of the channel and produced similar concentration, and voltage dependent 
subconductance behavior in RyR.  In contrast, the local anesthetics tetracaine and 
procaine are thought to inhibit RyR via an allosteric mechanism due to their lack of 
voltage dependence and membrane sidedness (87, 88).  Proposed binding site(s) for these 
compounds lie in or close to the lipid bilayer (87).   
 The Woodhull theory of pore block is a plausible mechanism which allows for 
definite predictions to be made and tested.  One testable prediction of this model is that 
the steepness of the voltage dependence depends upon the valence of the blocking species 
and the location of the binding site within the electric field across the channel.  Therefore, 
the voltage dependence of block is expected to vary with the charge of the blocking 
species.   This line of evidence has been used to determine the mechanism by which 
transmembrane potential influences the probability of RyR modification by ryanodine.  
Ryanodine modification of RyR produces a long-lived subconductance state.  Several 
ryanodine derivatives known a ryanoids also induced a subconductance state by 
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competing with ryanodine for a high affinity site on the channel (89-91).  The interaction 
of one such positively charged ryanoid (21-amino-9α-hydroxyryanodine) with the 
channel was strongly influenced by transmembrane voltage (92).  Both the rate of 
association and dissociation were voltage dependent.  This voltage dependent interaction 
could result from translocation of the ryanoid to a site within the voltage drop across the 
channel (i.e. direct pore block), or a voltage-driven alteration in binding site affinity for 
the ryanoid (i.e. allosteric mechanism).  The extent of equilibrium [3H]ryanodine binding 
is increased by activating ligands such as ATP and decreased by inhibitory ligands such 
as Mg2+ suggesting the high affinity binding site is only accessible when the channel is 
open (27, 28).  Additionally, the rate of association of 21-amino-9α-hydroxyryanodine 
with RyR was linearly dependent on channel Po (92).  Together these features of the 
interaction of ryanoids with RyR are consistent with location of a binding site within the 
conduction pathway accessible only when the channel is open.  However, a study 
comparing the interactions of a positively charged and neutral ryanoid with RyR showed 
the rate constants for ryanoid association and dissociation were unchanged by valence 
(93).  The lack of an effect of valence on the voltage dependence of ryanoid interaction is 
inconsistent with the Woodhull model and thus difficult to reconcile with a mechanism of 
direct pore block.  Therefore, the mechanism by which ryanodine modifies RyR 
conductance is unclear as evidence to support either an allosteric or direct block 
mechanism exists.     
 Predictions based on the Woodhull model have also provided insight into the 
mechanism underlying ‘block’ of Na+ channels by saxitoxin and related compounds.  
Saxitoxin produces voltage dependent all-or-none ‘blocking’ events in single Na+ 
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channels (94).  Several natural derivatives of saxitoxin (i.e. guanidinium toxins) ‘block’ 
Na+ channels with varying affinities and kinetics of action.  Importantly, these toxin 
derivatives have different net charges ranging from 0 to +2 (94).  Contrary to 
expectations for the case of toxin binding to a site within the electric field (presumably 
within the pore), toxin charge was shown to have no effect on the voltage dependence of 
blocking rates.  Therefore, direct pore block was abandoned, and the alternatively theory 
of voltage-driven changes in channel conformation was proposed to account for the 
effects of voltage on toxin binding.   
 
1.4.2. Varying driving force for ion flux 
 Another line of evidence to suggest that a ‘blocker’ binding site is actually within 
the pore involves competition with permeant ions.  By changing the concentration of 
permeant ions on one side of the channel, one can manipulate the driving force for ion 
flux through the channel pore.  If a ‘blocking’ species binds to a site within the 
permeation pathway, varying driving force is expected to affect the binding, and thus the 
‘blocking’ effect.  In a series of experiments (95-97) Clay Armstrong investigated the 
mechanism underlying block of inward rectifier K+ channels by intracellular TEA.  His 
experiments suggest that the TEA binding site lies within the channel pore, and is only 
accessible from the cytoplasmic side when the channel gate is opened by a depolarizing 
pulse.  A pivotal finding was that the TEA dissociation rate increased by external K+ 
especially at membrane potentials that elicit inward K+ currents.  This finding suggested 
that the voltage driven movement of K+ ions through the pore effectively ‘knock’ TEA 
ions off a binding site in the pore located near the cytoplasmic end of the channel. 
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1.4.3. Kinetic behavior of ‘blocking’ events 
 It is possible, with kinetic analysis of single channel activity, to obtain very 
detailed information about mechanisms determining channel conductance and gating.  
Thus, models describing kinetic behavior of channels in the presence of a ‘blocking’ 
agent are instructive.  Analysis is based upon the assumption that ‘blocking’ events 
represent the residence time of the ‘blocking’ agent at its binding site on the channel.  
Figure 3 depicts a simple two state model describing a reversible binding reaction.  The 
significance of this model is that it is only realistic in the case of direct pore block (i.e. 
the physical interaction the ‘blocking’ species with the permeation pathway).  According 
to this scheme the blocker (X) binds to and blocks the open channel (O).  Therefore, 
lifetime of the open state (O) is inversely proportional to the rate of X binding, which in 
turn is dependent on the concentration of X.  Lifetime of the blocked state (B) is 
determined by the residence time of X at its site, a parameter which is independent of 
[X].  Thus for the case of direct pore block, the lifetime of the open and blocked states 
should be inversely proportional to [X] and independent of [X], respectively.    
 Often, predictions based on a reversible binding scheme (Fig. 3) do not fit the 
measured kinetics of ‘block’, and are more adequately described by an allosteric model 
(Fig 4).  Figure 4 depicts a hypothetical allosteric model describing voltage driven 
changes in channel conformation analogous to the mechanisms proposed for the voltage 
dependent ‘block’ of Na+ channels by guanidinium toxins, and the voltage dependent 





Figure 3. Reversible binding scheme for classic open channel block.  The species (X) 
produces a blocked state (B) by entering the pore of the open channel (O).  This scheme 
predicts that the lifetime of the open state (O) to be inversely proportional to the 
concentration of X and the lifetime of the blocked state (B) to be independent of [X]. 
 





Figure 4. Hypothetical Scheme to explain voltage dependent modification of channel 
conductance.  S represents a ligand binding site on the channel which exists in either a 
high affinity (S1) or low affinity (S2) form.  The rate constants for X binding (k1, k2) and 
unbinding (k-1, k-2) are not voltage dependent.  Voltage dependent equilibrium (K3 and 
K4) between the high and low affinity channel conformations accounts for the apparent 




 The allosteric theory of channel ‘block’ states that non-conducting or 
subconductance events represent distinct channel conformations with altered ion 
permeation properties.  Two possibilities can be envisioned i) induced fit and ii) prior 
isomerization.  Induced fit describes a situation in which ligand binding produces a 
change in pore structure, with the conformation of the pore determined by the structure of 
the binding ligand.  Prior isomerization proposes that ligand binding stabilizes a channel 
conformation that has a very low probability of occurrence in the absence of ligand.  The 
allosteric scheme depicted in Figure 4 describes the situation of prior isomerization.  An 
important implication of this model is that conductance changes are intrinsic properties of 
ion channels which represent conformational changes in the channel protein.  This model 
describes the case in which the channel may adopt a minimum of two conformations, 
denoted by the subscripts 1 and 2, to which the ligand can bind.  The ligand binding site 
(S) is available on the channel in either a high affinity (S1) or low affinity (S2) form 
depending on channel conformation.  The apparent voltage dependence of the ligand 
interaction arises from a voltage dependent equilibrium between the two intrinsic channel 
conformations (the equilibrium constants K3 and K4 are voltage dependent).  Take for 
example the interaction of ryanoids with RyR.  Both rates of association and dissociation 
of ryanoids vary with applied holding potential; kon increases and koff decreases as the 
potential is shifted to more positive values.  In this scheme, positive potentials shift the 
equilibrium towards S1, the high affinity conformation, thus accounting for the increased 
rate of ryanoid association with increasing positive potentials.   
 An analogous circular 4 state model (Fig. 5) was proposed by Schild and 
colleagues to describe Zn2+ induced subconductance events in cardiac Na+ channels (98).  
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In the presence of external zinc ions, Na2+ channels transitioned between at least four 
distinct current levels.  The primary effect of Zn2+ was the induction of flickery closings 
to a low amplitude subconductance state.  The rate of Zn2+ association with Na+ channels 
was voltage dependent; kon increased with hyperpolarization (increasing negative 
membrane potential) suggestive of a pore block mechanism.  However, the observed 
dependence of both kon and koff on Zn2+ concentration was incompatible with a simple 
blocking model (Fig. 2).  As Zn2+ concentration was increased the lifetime of the open 
full conductance state (O) decreased and the lifetime of the open subconductance state 
(S) increased indicating that Zn2+ can bind to O, but preferentially binds to and stabilizes 
an intrinsic subconductance conformation (S).  These findings are consistent with the 
allosteric mechanism of prior isomerization, implying that the subconductance state is an 
inherent characteristic of Na+ channel gating. 
 Kinetic evidence has provided insight into the mechanism underlying ruthenium 
red block of RyR. Ruthenium red (RR) has a linear structure consisting of three 
ruthenium atoms which serve as a nucleus for a total of 14 amino groups ([(NH3)5Ru-O-
Ru(NH3)4-O- Ru(NH3)5] 6+; it is one of the most potent inhibitors of SR Ca2+ release (99).  
Both the pore block and allosteric mechanism has been proposed by (different groups) to 
account for the effects of RR on single RyR channel currents.  At the single channel 
level, RR caused long term closure which was irreversible on the time scale of single 
channel recordings and thus incompatible with kinetic analysis (13).  Two different 
approaches have been used to circumvent this difficulty: investigating the kinetics of RR 
interaction with ryanodine modified channels, or channels maximally activated by Ca2+ 






Figure 5.  Allosteric mechanism of the Zn2+ induced subconductance state in cardiac Na+ 
channels.  Zn2+ can bind to the full open (O) and subconductance (S) channel 
conformations.  The Zn2+ binding site has a high affinity for Zn2+ when the channel is in 
the S conformation, and a lower affinity for Zn2+ when the channel is in the O 
conformation.  A voltage dependent equilibrium between O and S gives rise to the 











 Cytosolic RR produced voltage dependent “all-or-none flickery block of 
ryanodine activated channels”(100).  ‘Block’ became more pronounced at large positive 
potentials which favored movement of RR into the conduction pathway of the channel.  
From the luminal face, rather than producing flicker block, RR caused voltage dependent 
reduction of the amplitude of the long lived ryanodine modified subconductance state.  
Luminal (trans RR) only reduced current flow at negative potentials which favor 
movement of luminal RR into the pore.  A hill coefficient of two for the dose response 
curve suggested that multiple RR molecules are involved in the inhibition.  In ryanodine-
modified channels, the rate of RR ‘block’ (kon) but not the ‘unblocking’ rate (koff) showed 
dependence on RR concentration, consistent with a reversible binding reaction (Fig. 2).  
Ma proposed that multiple positively charged RR molecules enter the pore, resulting in 
reduction of single channel current.   
 In the ryanodine-unmodified RyR (maximally activated by Ca2+ and ATP) RR 
produced several subconductance states, which were dependent on channel activity, 
membrane potential, and sidedness of RR addition (101).  However, Xu and colleagues 
identified a voltage independent component to RR inhibition which they attributed to an 
interaction between Ca2+ regulatory and RR inhibition sites.  This mechanism may have 
been ‘masked’ in the previous study as ryanodine modification renders RyR insensitive to 
Ca2+ regulation.  Based on the observation that the rate of formation, but not the 
amplitude, of the RR-related subconductance states was dependent on RR concentration, 
Xu and colleagues disagreed with the pore block mechanism proposed by Ma.  Rather 
stating that “an alternative explanation is that the substates are the result of voltage- and 
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RR-dependent changes in channel protein conformation.”  Thus the mechanism 
underlying RR inhibition of RyR is still unclear. 
 
1.4.4. Mutagenesis and structural data 
 Results from classical biophysical experiments may be indicative of a mechanism 
of action; however, effects of mutations within the pore on block, and visualization of 
blocking species in the pore in crystallized structures of channels provide the most 
compelling evidence for distinguishing between a pore block and allosteric mechanism.  
Several venoms used by organisms for defense purposes contain peptides that target ion 
channels.  As discussed previously, the effect of guanidinium toxins on Na+ channel 
conductance was not adequately described by a simple model of pore block.  Similarly, 
apamin modification of K+ channels, and the effect of scorpion toxins on RyR appear to 
involve an allosteric mechanism.   
 Apamin is an 18 amino acid peptide toxin isolated from bee venom which inhibits 
Ca2+ activated K+ channels (KCa) with high affinity and specificity.  A recent study 
employe site directed mutagenesis,  125I-apamin binding, and molecular modeling of 
ligand-channel interactions suggested that apamin ‘blocks’ via an allosteric mechanism 
(102).  In mutant channels, the replacement of a basic histidine residue located in the 
outer pore region with an uncharged asparagine abolished 125I-apamin binding.  
Functional studies showed that currents of mutant channels were no longer ‘blocked’ by 
apamin.   Molecular modeling of apamin interacting with the outer pore histidine 
positioned the toxin a large distance from the ion conduction pathway, making it unlikely 
for apamin to physically occlude the passage of ions through the selectivity filter.  A prior 
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study showed that H+ ions likely inhibit macroscopic currents through KCa via an 
allosteric mechanism involving protonation of the outer pore histidine residue (103).  Via 
an analogous mechanism, positively charged residues on apamin may mimic protons and 
interact with the outer pore histidine residue to promote a conformational change in the 
channel which affects ion permeation.   
   Toxins isolated from scorpion venom bind with high affinity to RyRs. 
Imperatoxin activator (IpTxa) and maurocalcin (MCa) from the venom of the scorpions 
Pandinus imperator and Scorpio maurus palmatus selectively activate RyRs by inducing 
a long lived subconductance state.  IpTxa and MCa are basic peptides composed of 33 
amino acids and possess 82% sequence identity.  Their three dimensional structure is 
stabilized by disulfide bridges formed between three pairs of cysteine residues (104, 105).  
They modulate RyR gating from the cytoplasmic side in voltage and concentration 
dependent manner (106-108).   Although studies have not conclusively distinguish 
between a pore block and allosteric mechanism, experimental evidence is most consistent 
with a ligand-induced conformational change as the mechanism underlying the 
subconductance states produced by IpTxa and MCa (107, 108).  There is also structural 
support for an allosteric mechanism of action.  Cryo-electron microscopy and three-
dimensional image analysis suggesed the IpTxa binding site is far (~11 nm) from the 
center of the cytoplasmic side of the transmembrane region of the RyR channel (109).   
 
1.4.5. Summary of ion channel block 
 Evidence for entry into the pore varies depending on the channel ‘blocking’ 
species.  Open channel block is expected to be voltage dependent, reversed by ions from 
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the opposite side of the membrane, and consistent with a reversible binding kinetic 
scheme.  Results from classical biophysical experiments may strongly support one theory 
over the other.  However, effects of mutations within the pore on block, and visualization 
of blocking species inside (or ouside) the pore in crystallized structures of channels 
provide the most compelling evidence for a direct pore block (or allosteric) mechanism.     
 
1.5. S-Adenosyl-L-Methionine 
 S-Adenosyl-L-Methionine is formed from the essential amino acid methionine 
and adenosine triphosphate (ATP).  It functions as a methyl group donor in a vast number 
of reactions catalyzed by a diverse class of enzymes known as methyltransferases (110).  
SAM plays an important role in cellular metabolism as a precursor molecule to three 
main pathways: methylation, transulfuration, and aminopropylation (111).  The 
aminopropylation pathway leads to the synthesis of polyamines, and the transulfuration 
pathway leads to the synthesis of glutathione.  
 
1.5.1. Structure and Chemistry 
 SAM is present in cells at a concentration of 60-90 μM (112, 113).  Although all 
cells synthesize SAM, the liver serves as the major site for its synthesis and degradation 
(111).  The synthesis of SAM is catalyzed by methionine adenosyl transferase (MAT, aka 
S-adenosyl-l-methionine synthetase).  This reaction involves the transfer of the adenosyl 
moiety of ATP to methionine forming a sulfonium ion which readily transfers its methyl 
group to a large variety of acceptor substrates including nucleic acids, proteins, 
phospholipids, and a long list of small molecules (110).    
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 The first step in mammalian methionine metabolism is its conversion to SAM and 
transfer of the methyl group to a variety of methyl acceptors.  Up to half of the daily 
intake of methionine is converted to SAM and about 85% of methylation reactions take 
place in the liver.  Factors influencing intracellular SAM levels include availability of 
methionine, SAM utilization for polyamine synthesis, and the type of MAT expressed 
(111).  Most of the SAM synthesized is used in transmethylation reactions.  A diverse 
class of enzymes known as methyltransferases catalyze the transfer of the methyl group 
from the sulfonium of SAM to the oxygen, nitrogen, or sulfur atom of biological targets 
(114).  The end products of this reaction are a methylated substrate, and S-adenosyl-L-
homocysteine (SAH), which is a potent inhibitor of methyltransferase activity. A 
decrease in the SAM to SAH ratio resulting from either an increase in SAH level or a 
decrease in the SAM level, has been shown to inhibit transmethylation reactions (115). 
  
1.5.2. Role in protein methylation 
 SAM serves an important biological function as the sole methyl donor in a 
multitude of cellular methylation reactions (110, 116).  Methylation of biological 
molecules is a mechanism for regulating a diverse array of physiological processes 
including, protein localization, and intermolecular interactions (117, 118).  Protein 
methylation can occur on the side chains of several amino acids: N-methylation of 
arginine, lysine, and histidine, O-methylation of glutamate and isoaspartate, and S-
methylation cysteine and methionine.  These reactions are catalyzed by highly protein- 
and amino acid-specific methyltransferases.  Most cells contain numerous SAM-
dependent methyltransferases that transfer the methyl group of SAM to the oxygen, 
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nitrogen, or sulfur atoms of target molecules.  Protein methylation can have a global 
effect on protein function via alterations in steric orientation, charge, or hydrophobicity 
(117).  Although protein methylation is regarded as a salient posttranslational regulator of 
protein function, relatively little has been reported on ion channel methylation.   
 The epithelial sodium channel (ENaC) was reportedly activated by methylation 
via a mechanism which involved regulation by the steroid hormone aldosterone (119, 
120).  However the site of methylation and enzyme involved remain to be determined.  
More recently, a proteomic study identified methylation of the α subunit of the cardiac 
sodium channel (Nav1.5) at three arginine residues.  Although the functional relevance of 
Nav1.5 methylation is unknown, two of the identified residues are known Nav1.5 
mutations causing Brugada and long QT type 3 syndromes (R526H and R680H 
respectively) (121).    
   
1.5.3. SAM regulation of Ryanodine Receptors 
 Interventions designed to increase cellular concentrations of SAM were shown to 
have a positive inotropic effect on the heart. This effect was attributed to lipid-
methylation which in turn stimulated the Sarco(endo)plasmic reticulum Ca2+ pump 
(SERCA) (122, 123).  However, the effects of this intervention on RyR2 were not 
investigated.  RyRs from coronary artery myocytes were reportedly activated by SAM 
(124).  However, smooth muscle expresses RyR1, RyR2 (125, 126), and RyR3 (127), 
therefore the results reported by Chen and colleagues reflect effects of SAM acting on 
multiple RyR isoforms (124).  FKBP was proposed to be the sole target of methylation 
resulting in its dissociation from RyR2 causing channel activation.  This is analogous to 
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the mechanism by which RyR2 hyperphosphorylation putatively results in FKBP12.6 
dissociation and channel activation (22).  The possibility that SAM regulation of RyRs 
involves a direct interaction with the channel has not been addressed. 
  
1.6. Introduction to research question: SAM regulation of Ryanodine Receptors 
 SAM has been shown to enhance cardiac contractile performance via effects on 
the SERCA pump (122, 123).  Ryanodine receptors from coronary artery myocytes were 
reportedly activated by SAM via an indirect mechanism involving protein methylation 
(124).  However, smooth muscle expresses RyR1, RyR2 (125, 126), and RyR3 (127), 
therefore the effects of SAM on a defined RyR isoform are unclear.     
   This work was undertaken to characterize the effects of SAM on a specific RyR 
isoform, RyR2, and to clarify the mechanism underlying RyR2 regulation by SAM.  
Initial work described in chapters 2 and 3 distinguish between SAM regulation of RyR2 
via its established role as a biological methyl group donor and SAM acting as a 
regulatory ligand with consideration of SAM binding to the well-established RyR2 
adenine nucleotide binding site(s). The potential interaction of SAM with the RyR2 
adenine nucleotide regulatory sites has important implications for clarifying the structural 
basis of ATP regulation of the channel.  During the course of this project the novel 
observation of a SAM related RyR2 subconductance state was made, thus work described 
in chapter 4 distinguishes between the two possible mechanisms by which SAM could 
reduce RyR2 conductance: i) SAM interfering directly with ion permeation via binding 
within the conduction pathway, or ii) the binding of SAM at a regulatory (or allosteric) 
site which stabilizes or induces a reduced conductance conformation of the channel. 
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Chapter 5 summarizes the major findings and proposes future directions.      
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CHAPTER 2 
S-ADENOYL-L-METHIONINE ACTIVATES THE CARDIAC RYANODINE 
RECEPTOR 
Kampfer, A. J., and Balog, E. M. (2008), Biochem Biophys Res Commun 371, 606-609. 
 
2.1. Abstract 
S-Adenosyl-L-methionine (SAM) is the biological methyl-group donor for the enzymatic 
methylation of numerous substrates including proteins. SAM has been reported to 
activate smooth muscle derived ryanodine receptor calcium release channels. Therefore, 
we examined the effects of SAM on the cardiac isoform of the ryanodine receptor 
(RyR2). SAM increased cardiac sarcoplasmic reticulum [3H]ryanodine binding in a 
concentration-dependent manner by increasing the affinity of RyR2 for ryanodine. 
Activation occurred at physiologically relevant concentrations. SAM, which contains an 
adenosine moiety, enhanced ryanodine binding in the absence but not in the presence of 
ATP. S-Adenosyl-L-homocysteine (SAH) is the product of the loss of the methyl-group 
from SAM and inhibits methylation reactions. SAH did not activate RyR2 but did inhibit 
SAM-induced RyR2 activation. SAH did not alter adenine nucleotide activation of RyR2. 
These data suggest SAM activates RyR2 via a site that interacts with, but is distinct from, 
the adenine nucleotide binding site. 
 
2.2. Introduction 
In the heart, ryanodine receptor calcium release channels (RyR2) are the efflux 
pathway by which calcium is released from the sarcoplasmic reticulum (SR) to initiate 
cardiac contraction. RyR2 is regulated primarily by Ca2+, although the biphasic Ca2+ 
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dependence of channel activation can be modified by numerous endogenous ligands and 
post-translational modifications (18, 128).  
S-Adenosyl-Lmethionine (SAM) is the biological methyl-group donor for a 
multitude of methylation reactions including protein methylation which alters protein-
protein interactions and protein function (117, 118). Experimental interventions designed 
to elevate cellular SAM concentrations had a positive inotropic effect on the heart (122, 
123). This work attributed the effect to increased activity of the SR Ca2+ ATPase but did 
not explore possible affects on RyR2. Recently, Chen et al (124) showed that SAM 
activated RyR channels derived from bovine coronary smooth muscle. The activation was 
attributed to the methylation and subsequent dissociation of the RyR accessory protein 
FKBP12. Because smooth muscle RyR expression is heterogenous, with cells containing 
all three RyR isoforms (125-127), one aim of the present work was to use cardiac 
sarcoplasmic reticulum to determine the affects of SAM on a defined channel isoform, 
RyR2. 
SAM is produced when the adenosyl moiety of adenosine triphosphate (ATP) is 
transferred to methionine, forming a sulfonium ion which can easily transfer its methyl 
group to numerous biological substrates including proteins and phospholipids.  Methyl-
group transfer converts SAM to S-adenosylhomocysteine (SAH), a potent competitive 
inhibitor of transmethylation reactions (111).  
Adenine nucleotides are important endogenous RyR regulators. Among these 
nucleotides, ATP is the most potent channel activator and the efficacy of channel 
activation decreases as phosphate groups are lost (60, 61). Thus, it appears that the 
number of phosphates are critical determinates of activation efficacy. Indeed, adenosine 
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binds RyR2 with high affinity but fails to open the channel causing adenosine to be a 
competitive inhibitor of ATP activation (60, 61); but see (129) for conflicting results]. 
The presence of an adenosine moiety in SAM raises the possibility that the SAM-induced 
RyR activation may be due to SAM binding to the RyR adenine nucleotide binding site. 
Thus, the second aim of this work was to determine whether there is an interaction 





  Pigs were purchased from Clemson University Research Farm Services. 
Unlabeled ryanodine was obtained from Calbiochem (La Jolla, CA). Adenosine 5′-(β,γ-
imido)triphosphate tetralithium salt (AMPPNP), S-(5’-adenosyl)-L-methionine chloride 
(SAM) and S-(5’-adenosyl)-L-homocysteine were obtained from Sigma (St. Louis, MO). 
[3H]Ryanodine was obtained from PerkinElmer (Waltham, MA). 
 
2.3.2. Isolation of Cardiac Sarcoplasmic Reticulum (CSR) vesicles 
  Animals were euthanized in accordance with Public Health Service Policy on 
Humane Care and Use of Laboratory Animals and with the approval of the Institutional 
Animal Care and Use Committee of the Georgia Institute of Technology. Animals were 
first anesthetized by subcutaneous injection of ketamine (20 mg/kg) and xylazine (2 
mg/kg) followed by euthanasia by intravenous injection of sodium pentobarbital (100 
mg/kg). Hearts were rapidly excised and rinsed in ice-cold 10 mM sodium bicarbonate 
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buffer. Ventricles were trimmed of excess fat and connective tissue. Minced ventricular 
tissue was homogenized in 10 mM NaHCO3 and centrifuged for 5 mins at 4,000 x g. The 
supernatant was filtered through gauze, centrifuged for 20 mins at 4,000 x g, filtered a 
second time and centrifuged 30 mins at 80,000 x g. Pelleted membranes were extracted in 
0.6 M KCl and 20 mM Tris (pH 6.8) on ice for 45 mins then centrifuged 30 min at 
120,000 x g. The pellets were resuspended in 10% sucrose, centrifuged 30 mins at 
120,000 x g and resuspended in a minimal volume of 10% sucrose. CSR was frozen in 
liquid N2 and stored at -70oC.  All buffers contained 1 µg/ml aprotinin, 1 µg/ml leupeptin, 
1 µg/ml pepstatin A, 1 mM benzamidine, and 1 mM phenylmethylsulphonylfluoride. 
 
2.3.3. [3H]Ryanodine Binding 
  Ryanodine binds with high affinity and selectively to RyRs in the open state; 
thus, CSR vesicle [3H]ryanodine binding measurements are sensitive indicators of RyR2 
channel activity (28, 130). CSR vesicle (0.4 mg/ml) binding media contained 7 nM 
[3H]ryanodine, 150 mM KCl, 20 mM K-Pipes, pH 7.0, 0.1 mg/ml bovine serum albumin, 
1.0 μg/ml leupeptin, 1.0 μg/ml aprotinin, and Ca-EGTA buffer to achieve the desired free 
Ca2+ concentration (131). Estimates of maximal [3H]ryanodine binding capacity of CSR 
vesicle preparations were made in parallel with each experiment in media that in addition 
contained 600 mM KCl, 10 mM ATP, 100 μM Ca2+ and 50 nM [3H]ryanodine. 
Nonspecific binding was measured in binding media that also contained 10 mM MgCl2 
and 20 μM nonradioactive ryanodine. After 20 hrs at room temperature (20-22oC) CSR 
vesicles were collected on Whatman GF/B filters and washed with 8 mls of ice-cold 100 
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mM KCl buffer. Radioactivity retained by the filters was determined by liquid 
scintillation counting. All assays were performed in duplicate. 
2.3.4. Analysis   
 The Ca2+ dependence of ryanodine binding was fit with an equation that assumes 
a high affinity Ca2+-binding site, which when bound will activate the RyR, and a lower 
affinity Ca2+ binding site, which when bound will inhibit channel opening (132). The 
effects of SAM on maximal CSR vesicle [3H]ryanodine binding capacity (Bmax) and 
dissociation constant (Kd) were determined by saturation analysis using non-linear curve 
fitting of equation 1 to binding isotherms.  
 
Equ. 1: 
 [3H]Ryanodine Bound = (Bmax X [Ryanodine])/(Kd + [Ryanodine]) 




 Data are presented as mean ± S.E.M. CSR [3H]ryanodine binding in the presence 
and absence of SAM, SAH, and AMPPNP, was analyzed using a one-way ANOVA with 
a Holm-Sidak multiple comparison as a post-hoc test or by Student’s paired or unpaired t-
tests as appropriate. Statistical analysis was performed using SigmaStat 3.1 (Systat 




In media containing 10 μM Ca2+, SAM increased CSR vesicle [3H]ryanodine 
binding in a concentration-dependent manner (Figure 6A). Binding in media containing ≥ 
75 μM SAM was significantly (p<0.05; n=5) increased compared to media lacking SAM. 
Binding increased 58, 63, and 113% in media containing 75 μM, 100 μM and 1 mM 
SAM respectively. To determine whether SAM activation of RyR2 was Ca2+-dependent, 
the Ca2+ concentration dependence of CSR ryanodine binding was performed in media 
containing either no SAM, 0.1 or 1.0 mM SAM (Figure 6B). In media containing 0.1 mM 
SAM the extent of CSR ryanodine binding at optimally activating Ca2+ was increased 
approximately 90% from 20.5±1.0% to 39.0±2.6% of maximal (p<0.05). Including 0.1 
mM SAM in the binding media did not alter the Ca2+ concentration required for half-
maximal ryanodine binding (EC50; No SAM: 2.92±0.29 μM, 0.1 mM SAM: 3.09±0.62 
μM), the Hill coefficient for Ca2+ activation (na; No SAM: 2.1±0.5, 0.1 mM SAM 
1.3±0.3) or Ca2+ inhibition (ni; No SAM: 1.3±0.2, 0.1 mM SAM:1.7±0.5). Including 0.1 
mM SAM caused a non-significant increase in the Ca2+ concentration required to half-
inhibit (IC50) ryanodine binding from 3.12±0.45 mM to 7.16±1.24 mM. Raising the SAM 
concentration in the binding media to 1.0 mM CSR caused a 160% increase in CSR 
ryanodine binding at optimal Ca2+ to 53.4±2.4% of maximal. In media containing 1 mM 
SAM, the Ca2+ IC50 was further increased to 12.8±2.3 mM and was significantly different 
from the Ca2+ IC50 in the absence of SAM (p<0.05). Compared binding in the absence of 
SAM, including 1.0 mM SAM in the binding media did not significantly alter the Ca2+ 
EC50 (2.92±0.38 μM), the na (1.4±0.2) or the ni (1.4±0.4). In media containing 100 nM 
Ca2+ SAM did not significantly increase CSR vesicle ryanodine binding (0.03±0.17, 
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0.77±0.21 and 1.32±0.56% of maximal in media containing no SAM, 0.1 mM SAM and 
1.0 mM SAM respectively). Thus, SAM increased RyR2 Ca2+ activation but did not 
alone activate RyR2 and at 1 mM SAM increased the Ca2+ concentration required to 
inhibit ryanodine binding.  
Saturation analysis was then carried out to determine whether SAM enhanced 
CSR vesicle ryanodine binding by increasing the affinity of RyR2 for ryanodine or if 
SAM increased the number of channels which bind ryanodine. Figure 7 summarizes these 
experiments. In media containing 30 µM Ca2+, SAM significantly increased CSR affinity 
for ryanodine, decreasing the Kd from 13.8±1.5 nM in the absence of SAM to 9.5±0.8 nM 
in media containing 0.1 mM  SAM (p<0.05, n=7). Including 0.1 mM SAM in the CSR 
ryanodine binding media did not significantly alter the maximal ryanodine binding 
(Bmax). In the absence of SAM Bmax was 1.16±0.04 pmol/mg and in media containing 0.1 







Figure 6. S-Adenosyl-L-methionine increased CSR vesicle ryanodine binding. A. S-
Adenosyl-L-methionine concentration dependence of CSR vesicle [3H]ryanodine 
binding. Binding was performed as described in the Methods in media containing 10 μM 
Ca2+ and the indicated concentration of SAM. SAM significantly increased ryanodine 
binding at all concentrations ≥75 μM (p<0.01, n=5).  B. Ca2+ concentration dependence 
of CSR vesicle ryanodine binding. Binding was performed as described in the Methods in 
media containing the indicated concentration of Ca2+ and either no SAM (○), 0.1 mM 







Figure 7. Saturation analysis of the effects of SAM on CSR [3H]ryanodine binding (○ No 
SAM;● 0.1 mM SAM) . Binding was performed as described in the Methods in media 
containing 3 µM Ca2+ and the indicated concentration of ryanodine. SAM (0.1 mM) 
significantly increased CSR affinity for ryanodine; Kd: No SAM=13.8±1.5 nM; 0.1 mM 
SAM=9.5±0.8 nM, p<0.05. The maximal CSR ryanodine binding was not significantly 
altered by SAM (Bmax: No SAM=1.16±0.04 pmol/mg; 0.1 mM SAM= 1.29±0.04 




Adenine nucleotides are well characterized endogenous RyR2 regulators. Because 
SAM is an adenosine containing compound the possibility that SAM activates RyR2 via 
the adenine nucleotide binding site was investigated. AMPPNP, the non-hydrolyzable 
analog of ATP, was used in these experiments to avoid the potential confounding effect 
of RyR2 phosphorylation. To determine whether there is an interaction between SAM 
and AMPPNP activation of RyR2, the AMPPNP concentration dependence of CSR 
ryanodine binding was performed in the absence and presence of 0.1 mM SAM (Figure 
8). In the absence of SAM, AMPPNP increased ryanodine binding with an EC50 of 90±10 
μM and a Hill coefficient of 0.91±0.05. Ryanodine binding was increased from 
13.5±1.3% of maximal in the absence of AMPPNP to 40.6±3.9% in 1 mM AMPPNP. 
Including 0.1 mM SAM in the binding media did not significantly alter either the 
AMPPNP EC50 (100±7 μM) or the Hill coefficient (0.66±0.24). In media containing 0.1 
mM SAM, ryanodine binding increased from 21.5±2.7% in the absence of AMPPNP to 
43.9±3.6 in 1 mM AMPPNP. The addition of 0.1 mM SAM to the binding media 
significantly increased CSR vesicle ryanodine binding in the absence of AMPPNP and in 
combination with the lowest concentration (0.01 mM) AMPPNP but did not alter the 
maximal extent of CSR ryanodine binding in media containing ≥0.3 mM AMPPNP. The 
lack of an additive effect of SAM plus AMPPNP suggests that either SAM and AMPPNP 
act via a common site or they act via distinct but interacting sites. 
 SAH differs from SAM only by the loss of a methyl group and is a competitive 
inhibitor of methyltransefrase reactions. However, its use in examining methylation-
induced activation of RyR2 is complicated by its possible interaction with the adenine 
nucleotide binding site. Thus, we determined the affects of SAH on both SAM and 
 50
AMPPNP activation of RyR2. The dependence of CSR vesicle [3H]ryanodine binding on 
the SAM concentration, the SAH concentration, and SAM concentration in media 
containing 0.4 mM SAH is shown in Figure 9A. CSR vesicle ryanodine binding was 
significantly increased in media containing ≥0.1 mM SAM (p<0.05, n=8). In contrast, 
including up to 0.4 mM SAH in the binding media did not significantly increase 
ryanodine binding. Importantly, including 0.4 mM SAH in the ryanodine binding media 
prevented the SAM-induced increase in CSR ryanodine binding. This is consistent with 
the previously reported SAH block of SAM-induced activation of vascular smooth 
muscle RyRs [10].  If SAM activates RyR2 via the adenine nucleotide binding site, a 
possibility raised by the results shown in Figure 8 and SAM activation is prevented by 
SAH, then SAH should also block AMPPNP activation of the channel. Thus, the 
AMPPNP concentration dependence of ryanodine binding was determined in the absence 
of SAH and in media containing 0.4 mM SAH. Figure 9B shows that including ≥0.2 mM 
AMPPNP in the ryanodine binding media significantly increased CSR ryanodine binding 
(p<0.05, n=3). However, in contrast to SAH block of the SAM-induced increase in CSR 
ryanodine binding, including 0.4 mM SAH in the binding media had no effect on the 






Figure 8. AMPPNP concentration dependence of CSR vesicle [3H]ryanodine binding in 
the presence (●) and absence (○) of SAM. Ryanodine binding was performed as 
described in the Methods in media containing 3 µM Ca2+ and the indicated concentration 
of AMPPNP ± 0.1 mM SAM. AMPPNP (≥0.1 mM) significantly increased CSR 
ryanodine binding. The addition of 0.1 mM SAM to the binding media significantly 








Figure 9. SAH blocked SAM activation but not AMPPNP activation of RyR2. A. CSR 
vesicle ryanodine binding was performed as described in the Methods in media 
containing 1 μM Ca2+ and the indicated concentration of SAM (○), SAH (▼) or SAM + 
0.4 mM SAH (●); n=8. SAM at concentrations ≥ 0.1 mM significantly increased CSR 
vesicle ryanodine binding (* indicates significantly different from 0 SAM, p<0.05). CSR 
vesicle [3H]ryanodine binding in media containing up to 0.4 mM SAH was not 
significantly different from binding in media containing no SAM. Including 0.4 mM 
SAH in media containing increasing concentrations of SAM prevented the SAM-induced 
increase in CSR ryanodine binding. B. Ryanodine binding was performed as described in 
the Methods in media containing 1 μM Ca2+, and the indicated concentration of 
AMPPNP (○) or the indicated concentration of AMPPNP + 0.4 mM SAH (●). * 
Significantly different from 0 AMPPNP (p<0.05, n=3). + Significantly different from 0.4 





SAM is the biological methyl-group donor for a multitude of methylation 
reactions. Protein methylation was noted over 40 years ago (133) and has come to be 
appreciated as a common and important post-translational reaction regulating protein-
protein interaction and protein function (117, 118). Indeed, epithelial Na+ channels are 
regulated via a methylation reaction (134) and plant aquaporin channels have recently 
been shown to be methylated (135). RyRs may also be regulated by protein methylation. 
Chen et al (124) attributed the SAM-induced increase in the open probability of vascular 
smooth muscle RyRs to the methylation and subsequent dissociation of the RyR 
accessory protein FKBP. However, determining the mechanism of RyR activation by 
SAM is complicated by the possibility that SAM, via its adenosine moiety, binds the RyR 
adenine nucleotide binding site.  
We examined the effects of SAM on [3H]ryanodine binding to SR vesicles 
derived from cardiac ventricles, a tissue in which RyR expression is nearly exclusively 
RyR2 (136). We found that SAM concentrations ≥ 75 µM increased CSR vesicle 
ryanodine binding (Figure 6A) by increasing the affinity of RyR2 for ryanodine (Figure 
7). The concentration of SAM in mammalian cells has been reported to be 60 – 90 µM 
(112, 113). Thus concentrations of SAM required to activate RyR2 in vitro are within the 
physiological concentration range. 
RyR2 activation by SAM was similar to activation by adenine nucleotides in that 
both compounds enhance Ca2+ activation of the channel but have minimal effects of 
channel activity in the absence of Ca2+ (32, 45). SAM did not increase ryanodine binding 
in sub-micromolar Ca2+ or decrease the Ca2+ EC50 but rather increased the Ca2+ IC50 
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(Figure 6B).  Thus SAM activation required the presence of activating concentrations of 
Ca2+. 
If SAM and adenine nucleotides share a common activating site or the two sites 
are allosterically coupled, activation by the two compounds should be less than additive. 
Indeed, that is what is shown in Figure 9, SAM increased CSR ryanodine binding in 
media containing ≤0.01 mM AMPPNP but in media containing ≥0.03 mM AMPPNP, 
SAM did not enhance binding.  Thus, there appears to be an interaction between RyR2 
activation by SAM and AMPPNP. SAH differs from SAM simply by the loss of the 
sulfonium methyl group. Thus, like SAM, SAH could potentially bind to the RyR 
adenine nucleotide binding site. However, it is clear from Figure 9 that in spite of the 
close structural similarities between SAM and SAH, SAH did not activate RyR2.  It is 
possible that SAH at higher concentrations may increase CSR ryanodine binding, 
however, because of the low solubility of SAH we were limited to the concentration 
range shown in Figure 4.  Consistent with the previous report by Chen et al (124) SAH 
did however block RyR2 activation by SAM. A plausible hypothesis is that SAM 
activates RyR2 via the adenine nucleotide binding site and that the loss of the methyl 
group converts SAM from an agonist to an antagonist at the adenine nucleotide binding 
site. If SAH is indeed an antagonist, it should decrease AMPPNP activation of RyR2. As 
shown in Figure 9, AMPPNP significantly enhanced CSR ryanodine binding. This 
activation of RyR2 was not altered by SAH, suggesting SAH does not interact with the 
adenine nucleotide binding site. Thus the SAH block of SAM activation and lack of 
affect of SAH on AMPPNP activation suggests SAM activation of RyR2 occurred via a 
mechanism distinct from, but interacting with, the adenine nucleotide binding site. 
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The results presented here show that RyR2 can be activated by physiologically 
relevant concentrations of the biological methyl-group donor SAM. Thus, SAM may be a 





S-ADENOSYL-L-METHIONINE REGULATION OF THE CARDIAC 
RYANODINE RECEPTOR INVOLVES MULTIPLE MECHANISMS 




Cardiac contraction is triggered by the release of Ca2+ via the ryanodine receptor (RyR2), 
a sarcoplasmic reticulum (SR) resident ion channel. RyR2 channel activity is modulated 
through ligand binding and posttranslational regulatory mechanisms.  S-adenosyl-L-
methionine (SAM), the primary methyl group donor for enzyme-mediated methylation of 
proteins and other biological targets, activates RyR2 via an unknown mechanism (137). 
Here we show that the SAM induced increase in cardiac SR (CSR) vesicle [3H]ryanodine 
binding is unaffected by methyltransferase inhibitors, and immunoprecipitation of RyR2 
from S-adenosyl-L-[methyl-3H]-methionine ([3H]SAM) pre-treated CSR indicate that 
RyR2 is not a target of SAM mediated protein methylation. Because SAM contains an 
adenosine moiety and RyR2 is activated by ATP, we investigated whether SAM exerts its 
effects through the adenine nucleotide binding sites on the RyR2 channel.  In support of 
this hypothesis, the SAM and ATP concentration dependence of CSR vesicle 
[3H]ryanodine binding virtually overlap. Furthermore, ryanodine binding assays show 
that SAM competes with adenine nucleotide activation of RyR2, and the effects of SAM 
on mean channel open and closed times   follow similar trends as those observed for 
ATP. Interestingly, SAM but not ATP activation of RyR2 was associated with a marked 
increase in the percent of channel openings to a sub-conductance level ~ 60% of the 
maximal single channel conductance.  This work highlights the complexity underlying 
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SAM regulation of RyR2, and suggests ligand binding is among the multiple mechanisms 
responsible for SAM regulation of RyR2. 
 
3.2. Introduction 
The ryanodine receptor (RyR) is an intracellular Ca2+ channel located in the 
sarcoplasmic reticulum (SR) membrane which serves as a gated efflux pathway for stored 
Ca2+. Mobilization of intracellular Ca2+ via the cardiac isoform of the channel (RyR2) is 
the event which triggers contraction, thus, RyR2 plays a critical role in the contractile 
performance of the heart.  RyRs are high molecular weight homotetramers consisting of a 
C-terminal SR membrane spanning domain, and a large N-terminal cytoplasmic domain 
(15).  Each RyR tetramer exists in its native membrane as part of a macromolecular 
complex in association with a number of signaling molecules involved in 
posttranslational protein modification. The RyR is also subject to complex allosteric 
regulation by  metabolites, ions, and pharmacological agents (27). Physiological RyR 
regulatory ligands include Ca2+, Mg2+, ATP, and the accessory proteins calmodulin 
(CaM) and FK506 binding proteins (FKBPs).   
ATP activates RyR2 in a concentration and Ca2+ dependent manner (57), and is 
present in resting muscle at a concentration sufficiently high for it to function as a 
principal cellular regulator of RyR2 (59).  Although the degree to which adenine 
nucleotides (e.g. ATP and its metabolites) activate RyR2 varies, all are thought to interact 
with the same class of binding sites on the channel. The purine ring is important for 
agonist activity at these sites, as the replacement of adenine with guanine destroys the 
 58
ability of the nucleotide to modulate RyR (57). However, other structural features that 
determine the ability of adenosine based compounds to activate RyR2 are poorly defined.   
The biological methyl group donor S-adenosyl-L-methionine (SAM) participates in 
transmethylation reactions whereby the methyl group of SAM is transferred to proteins, 
nucleic acids, or lipids thereby altering the localization and/or function of the methylated 
target (112, 117, 138). Previous reports of a SAM-induced enhancement of cardiac 
contraction did not investigate the effects of SAM on RyR2 (122, 123).  More recently 
Chen et al (124) attributed SAM activation of RyRs from coronary artery myocytes to 
protein methylation causing the dissociation of the RyR accessory protein FKBP12. 
However, smooth muscle expresses RyR1, RyR2 (125, 126), and RyR3 (127), therefore 
the effects of SAM on RyRs from artery myocytes reflect SAM acting on multiple 
channel isoforms (124).   
In contrast to the effects of SAM observed by Chen and colleagues (124), our prior 
work suggests SAM activates RyR2 through a direct interaction with the channel (137). 
Importantly, SAM is an adenosine based compound which raises the possibility that 
SAM, like ATP, regulates RyR2 via the adenine nucleotide binding site/s.  In the present 
study we have examined the effects of SAM on a defined RyR isoform by utilizing 
cardiac SR (CSR) vesicle ryanodine binding and current recordings from native RyR2 
channels incorporated into phospholipid bilayers. Our primary aim was to clarify how 
SAM exerts its effect on RyR2 activity, specifically, whether SAM acts via a direct (e.g. 
ligand binding) or an indirect (e.g. posttranslational modification) mechanism.  In 
addition to the previously reported activation of RyR2 by SAM, we observe a distinct 
SAM induced channel sub-conductance state. Our data indicate that SAM directly 
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activates RyR2 through the adenine nucleotide binding site/s and suggests that sub-
conductance states result from an indirect effect of SAM on RyR2.     
 
3.3. Materials and Methods 
 
3.3.1. Materials 
 Pigs were purchased from Clemson University Research Farm Services.  
Unlabeled ryanodine and 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate 
(CHAPS) were obtained from Calbiochem (La Jolla, CA). Adenosine 5’-(b,c-
imido)triphosphate tetralithium salt (AMPPNP), S-(5’-adenosyl)-L-methionine chloride 
(SAM), S-(5’-adenosyl)-L-homocysteine (SAH), sinefungin, FK506, ATP, and ADP 
were obtained from Sigma (St. Louis, MO). [3H]Ryanodine and S-adenosyl-L-[methyl-
3H]-methionine ([3H]SAM) were obtained from Perkin-Elmer (Waltham, MA). 
FKBP12.6 antibodies were obtained from R&D Systems (#AF4174, Minneapolis, MN). 
RyR2 monoclonal antibody (clone C3-33) was from Sigma-Aldrich (St. Louis, MO). 
Horseradish preoxidase conjugated antibodies donkey anti-goat and goat anti-mouse were 
obtained from Santa Cruz Biotechnology (Santa Cruz, CA) and Millipore (Billerica, MA) 
respectively. EcoLite scintillation fluid and protease inhibitors were purchased from MP 
Biomedicals (Solon, OH).  ECL Plus Western Blotting detection system was from GE 
Healthcare. BioMax light film was obtained from KODAK.  Whatman GF/B filters were 
from Brandel, Inc. (Gaithersberg, MD), and BioTrace PVDF membranes were from Life 
Sciences (Pensacola, FL).  Recombinant Protein-G sepharose 4B beads were obtained 
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from Invitrogen (Carlsbad, CA).  Phosplolipids were purchased from Avanti Polar Lipids 
(Alabaster, AL). 
 
3.3.2. Isolation of cardiac sarcoplasmic reticulum vesicles 
 Cardiac SR (CSR) vesicles used for [3H]ryanodine binding were prepared from 
porcine ventricular tissue as previously described (139).  Animals were euthanized in 
accordance with the Public Health Services Policy on Humane Care and Use of 
Laboratory Animals and with the approval of the Institutional Care and Use Committee 
of the Georgia Institute of Technology. Briefly, animals were euthanized by intravenous 
injection of sodium pentobarbital (100 mg/kg) following sedation by subcutaneous 
injection of ketamine (20 mg/kg) and xylazine (2 mg/kg). Muscle was homogenized in 
ice-cold 10 mM NaHCO3 buffer and the supernatant from a 4,000 × g centrifugation was 
filtered through cheesecloth, re-centrifuged and retained. Membranes pelleted at 80,000 × 
g from the supernatant were extracted in 0.6 M KCl and 20 mM Tris (pH 6.8), 
centrifuged at 120,000 × g, and resuspended in a minimal volume of 10% sucrose. Heavy 
CSR vesicles isolated based on the method of Sitsapesan and Williams (140) were used 
for channel recordings as they incorporated more readily into phospholipid bilayers.  
Muscle was homogenized in a buffer containing 300 mM sucrose, and 20 mM 
piperazine-N,N’-bis(2-ethanesulfonic acid) (PIPES) (pH 7.4), centrifuged at 10,000 × g, 
and the retained supernnatant was centrifuged a second time at 87,000 × g.  The pelleted  
membranes were resuspended in a salt solution (400 mM KCL, 0.5 mM MgCl2, 0.5 mM 
CaCl2, 0.5 mM EGTA, 25 mM PIPES, pH 7.0)  containing 10% sucrose w/v. The mixed 
membrane suspension was layered upon discontinuous sucrose-density gradients 
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consisting of identical salt solutions containing 20%, 30%, and 40% sucrose w/v and 
sedimented at 100,000 × g.  Heavy CSR membrane vesicles collected at the 30-40% 
sucrose interface were diluted in 400 mM KCl, pelleted at 87,000 × g, and resuspended in 
a minimal volume of buffer containing 400 mM sucrose, and 5 mM 4-(2-hydroxyethyl)-
1-iperazineethanesulfonic acid (HEPES) (pH 7.2).  All isolation buffers contained a 
mixture of protease inhibitors (aprotinin, leupeptin, pepstatin A, benzamidine, and 
phenylmethylsulphonyl-fluoride). Vesicles were frozen rapidly in liquid N2 and stored at 
-80ºC.   
 
 3.3.3. [3H]SAM/SAM pretreatment of CSR vesicles and determination of [3H]methyl 
incorporation 
 CSR vesicles (4 mg/mL) were incubated in media containing 20 mM PIPES (pH 
7.0),  150 mM KCl, 0.285 μM (3 μ Ci) S-adenosyl-L-[methyl-3H]-methionine 
([3H]SAM), ± 1 mM S-adenosyl-L-homocysteine (SAH) and/or 500 fold excess unlabled 
SAM for 30 min at 37oC.  In a subset of experiments CSR was incubated as described 
above but in the presence of 0.1 or 2 mM unlabled SAM rather than [3H]SAM. Treated 
CSR vesicles were pelleted by centrifugation through 15% sucrose.  Pellets were washed 
by resuspension in 10% sucrose followed by centrifugation at 100,000 × g. Washed CSR 
vesicles were resuspended in a minimal volume of 10% sucrose, flash frozen in liquid N2, 
and stored at -80ºC. SAM treated heavy CSR used for channel recording experiments was 
resuspended in a minimal volume of buffer containing 400 mM sucrose, and 5 mM 
HEPES (pH 7.2). All buffers contained a mixture of protease inhibitors. For determining 
[3H]methyl incorporation, an aliquot of treated CSR vesicles (100  µg) was collected by 
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filtration onto Whatman GF/B filters, washed with 8 mL ice-cold 100 mM KCl, and the 
activity retained was measured by liquid scintillation counting.  
 
3.3.4. RyR2 Immunoprecipitation and determination of [3H]methyl incorporation 
 Control or [3H]SAM pretreated CSR vesicles (200 µg) were solubilized overnight 
at 4oC in buffer containing 3% CHAPS, 1.0 M NaCl, 20 mM Tris-HCl (pH 7.4), 1 mM 
dithiothreitol, and protease inhibitors and centrifuged at 12,000 × g for 10 min.  
Solubilized CSR was incubated for 2 hrs at 4ºC with or without a RyR2 specific antibody 
(1:100) with rotary mixing and for an additional 2 hrs followed by the addition of Protein 
G-Sepharose CL-4B beads (20 µl).  Beads were pelleted by centrifugation at 14,000 × g 
and washed twice with IP buffer containing 20 mM Tris-HCl (pH 7.4), 1.0 M NaCl, 0.4% 
CHAPS, and protease inhibitors.  Proteins were eluted from the affinity beads by boiling 
in sodium dodecyl sulfate (SDS)-sample buffer containing 10% SDS.  For determining 
[3H]methyl incorporation into immunoprecipitated samples, radioactivity of an aliquot 
(20 µL) of eluted proteins was determined by liquid scintillation counting. 
 
3.3.5. FK506 treatment of CSR vesicles 
 Treatment of CSR vesicles was based on the method of Ahern et. al. for the 
removal of FKBP12 from RyRs (141). CSR vesicles (2 mg/mL) were incubated at 37 ºC 
for 30 min in media containing 20 mM Imidazole (pH 7.4), 300 mM sucrose, protease 
inhibitors, and 10 uM FK506 (in ethanol) or an equivalent volume of ethanol as control.   
Vesicles were pelleted at 24,000 × g, washed in buffer, and repelleted before 
resuspension in a minimal volume of buffer.   
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3.3.6. Western Blotting 
  CSR vesicles and immunoprecipitated RyR2 samples were separated on 5% or 5-
20% gradient SDS-polyacrylamide gels using the buffer system of Laemmli (142) and 
transferred to PVDF membranes for 18 hrs at 30 V followed by 60 min at 200 V using a 
buffer of 25 mM Tris pH 8.3, 192 mM glycine, 20% methanol and 0.05% SDS at 4ºC.  
After blocking for 1 hr at room temperature in fresh 5% BSA in PBS containing 0.1 % 
Tween-20 (PBS-T), membranes were exposed to FKBP12.6 antibodies diluted to 1:1,000 
in PBS-T, 5% BSA and 0.5 M NaCl overnight at 4oC.  After washing and incubating in 
horseradish peroxidase conjugated conjugated donkey anti-goat IgG (1:100,000) for 1 hr 
at room temperature, reacted bands were visualized using enhanced chemiluminescence. 
Antibody complexes were stripped from the membrane by incubation in 100 mM 2-
mercaptoethanol, 2% SDS and 62.5 mM tris(hydroxymethyl)amino-methane pH 6.7 at 
50oC for 30 min. RyR2 was detected either after transfer of proteins to PDVF membranes 
or after stripping membranes previously probed for FKBP12.6. RyR2 monoclonal C3-33 
was used at a dilution of 1:50,000. The secondary horseradish peroxidase conjugated goat 
anti-mouse antibody was used at a dilution of 1:20,000. 
 
3.3.7. [3H]Ryanodine binding 
 [3H]Ryanodine binding measurements are sensitive indicators of RyR2 channel 
activity as ryanodine binds with high affinity and selectively to RyRs in the open state 
(28, 130).  Ryanodine binding buffer contained 0.4 mg/ml CSR vesicles, 7 nM 
[3H]ryanodine, 150 mM KCl, 20 mM K-PIPES (pH 7.0), 0.1 mg/ml BSA, 1.0 µg/ml 
leupeptin, 1.0 µg/ml aprotinin, and Ca2+–EGTA buffers to achieve the desired free Ca2+ 
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concentrations (131). Estimates of maximal [3H]ryanodine binding capacity of CSR 
vesicle preparations were made in parallel with each experiment in media that in addition 
contained 500 mM KCl, 5 mM ATP, 100 µM Ca2+, and 50 nM ryanodine.  Nonspecific 
CSR vesicle [3H]ryanodine binding was determined by inclusion of 10 mM MgCl2 and 
20 µM unlabled ryanodine in the binding media.  After 20 hr at room temperature (20–22 
ºC) CSR vesicles were collected on Whatman GF/B filters and washed with 8 ml of ice-
cold 100 mM KCl.  Radioactivity retained by the filters was determined by liquid 
scintillation counting.  The Ca2+ dependence of ryanodine binding was fit with an 
equation that assumes a high affinity Ca2+-binding site, which when bound will activate 
the channel, and a lower affinity Ca2+ binding site, which when bound will inhibit 
channel opening (132). All curve fitting was performed using SigmaPlot 9.0 (Systat 
Software, Point Richmond, CA).  All assays were performed in duplicate and were 
repeated using at least 4 different CSR vesicle preparations.  
 
3.3.8. Single channel recordings 
 Muller-Rudin bilayers were formed by painting a lipid mixture 
(phosphatidylethanolamine, phosphatidylserine, phosphatidylcholine, 5:3:2 ratio by wt, 
50 mg/ml dissolved in n-decane) across a 100 - 250 μm aperture in a Delrin cup.  To 
assist in vesicle fusion, an osmotic gradient was established across the bilayer.  Heavy 
CSR vesicles were added to the cis chamber which contained 250 mM cesium 
methanesulfonate, 10 mM HEPES (pH 7.4), and 1 mM CaCl2.  The trans chamber 
contained 50 mM cesium methansulfonate and 10 mM HEPES pH 7.4. After 
incorporation of channels into the bilayer, the concentration of cesium methansulfonate in 
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the trans chamber was raised to 250 mM and the cis chamber Ca2+ concentration adjusted 
by adding small aliquots of concentrated EGTA and CaCl2 (131). Small aliquots of 
concentrated channel regulators were added to the cis chamber with stirring prior to data 
acquisition. Voltage was controlled and channel currents were recorded using an 
Axoclamp 200B patch clamp amplifier (Molecular Devices). The cis and trans chambers 
were connected to the amplifier head stage by Ag/AgCl electrodes and agar salt bridges.  
The trans chamber was held at ground and current was applied to the cis chamber. 
Current was monitored on an oscilloscope, recorded at 5 kHz and signals were filtered at 
1 kHz.  Channel data were collected using a pulsing protocol in which the potential was 
held at 0 mV for 120 ms between steps of 4-s duration to -70 mV (CLAMPEX program, 
pCLAMP software, Axon instruments).   
 
3.3.9. Analysis of data 
 Only channels having a conductance of at least 400 pS were used for analysis. 
Single-channel current amplitudes were measured from digitized data using manually 
controlled cursors. Channel open probability (Po), open times, and closed times were 
determined by the half-amplitude threshold method with a threshold set so that openings 
to the maximum single channel conductance level (γmax)  and openings to the SAM 
related sub-conductance level (γsub) were included in the analyses.  Single channel Po was 
calculated from at least 30 4-s sweeps using FETCHAN and PSTAT analysis programs 
(pCLAMP software).  Frequently two channels incorporated into the bilayer, indicated by 
current amplitudes of twice the expected magnitude, and Po was estimated as the average 
Po of the two channels, calculated as [Po level 1 + (Po level 2 × 2)]/2.  Bilayers in which 3 
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or 4 channels had incorporated were treated similarly. The probability of openings to γsub 
(Po sub-state; ~20 pA) was calculated as time spent in γsub / total recording time.  The 
percentage of channel openings to sub-conductance levels was given by [Po sub-state / 
(Po sub-state + Po maximum single channel conductance level (≥ 20 pA)) × 100].   
 
3.3.10. Statistics 
 CSR [3H]ryanodine binding and [3H]methyl-group incorporation data are 
presented as means ± SEM and were analyzed using a one-way ANOVA with a Holm-
Sidak multiple comparison as a post-hoc test or by Student’s t-tests as appropriate.  
Occasionally data did not fit the assumptions required for a t-test, in which case a non-
parametric test was performed. Single channel open probabilities and dwell times are 
presented as means ± SEM analyzed using Student’s paired t-tests or Mann-Whitney 
Rank Sum test.  Statistical analysis was performed using SigmaStat 3.1 (Systat Software, 
Point Richmond, CA).  The level of significance was p < 0.05 unless otherwise noted. 
 
3.4. Results 
3.4.1. Effects of SAM on CSR vesicle [3H]Ryanodine binding 
  S-adenosyl-L-methionine (SAM) is a ubiquitous methyl group donor which is 
present in cells at a concentration of 60-90 µM (112, 113).  Previously we have shown 
that SAM (≥ 75 µM) significantly increases CSR vesicle [3H]ryanodine binding in a 
concentration dependent manner (137).  Thus, RyR2 is activated by a physiological 
concentration of SAM.  The effects of SAM on the Ca2+ concentration dependence of 
CSR vesicle [3H]ryanodine binding revealed that SAM activation of RyR2 is Ca2+ 
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dependent (Fig 10).  The effects of 0.1 and 1 mM SAM on the maximal Ca2+-induced 
CSR vesicle [3H]ryanodine binding (%Bmax), Ca2+ concentrations required to half-
maximally activate (EC50) and half-inhibit (IC50) binding, and the Hill coefficients for 
activation (na) and inhibition (ni) are given in Table 1.  In the presence of 0.1 mM SAM 
the Bmax and IC50 of CSR vesicle ryanodine binding increased significantly.  Inclusion of 
1 mM SAM in the binding media increased the %Bmax, IC50, and caused additional 
effects, significantly increasing the na, and decreasing the EC50. SAM did not 
significantly increase CSR [3H]ryanodine binding in media containing sub-activating 
Ca2+ concentrations (< 0.1 µM).  Thus, SAM did not alone activate RyR2 but enhanced 




Table 1.  Parameters from fits to Ca2+ concentration dependence of CSR vesicle [3H]Ryanodine binding.   
The Ca2+ concentration dependence of CSR vesicle ryanodine binding was performed as described in  
“Materials and Methods” in media containing the indicated Ca2+ concentration and either No Addition,  
0.1 mM SAM, or 1 mM SAM.  [3H]Ryanodine binding is expressed as percent of maximal [3H]ryanodine  
















26.7 ± 1.52 
 
1.37 ± 0.33 4.0 ± .83 1.01 ± 0.20 1.21 ± 0.59 
0.01 mM SAM 
 
38.0 ± 1.66# 
 
1.13 ± 0.26 9.69 ± 1.46* 0.88 ± 0.15 1.77 ± 1.31 
1 mM SAM 
 
55.3 ± 1.23† 
 














Figure 10.  Effects of SAM on Ca2+-dependent activation of RyR2. The Ca2+ 
concentration dependence of CSR vesicle ryanodine binding was performed as 
described in “Materials and Methods” in media containing the indicated Ca2+ 
concentration and either No Addition , 0.1 mM SAM, or 1 mM SAM. 
[3H]Ryanodine binding is expressed as percent of maximal [3H]ryanodine 
binding.  The solid lines are the fits to the Ca2+ concentration dependence (Bmax = 







3.4.2. Methyltransferase inhibitors do not block the SAM-induced increase in 
CSR vesicle ryanodine binding 
  SAM is the primary methyl group donor for the enzyme-mediated 
methylation of biological macromolecules.  Activation of RyR2 by SAM may 
therefore be the result of protein methylation.  S-adenosyl-L-homocysteine 
(SAH), a product of methyl group transfer from SAM to an acceptor molecule, 
inhibits methyltransferase activity by mass action, while sinefungin inhibits 
transmethylation reactions by competing for the SAM binding site on 
methyltransferases.  Figure 11  A shows the effect of 1 mM SAM on CSR vesicle 
[3H]ryanodine binding in the absence or presence of increasing concentrations of 
sinefungin (top panel) or SAH (bottom panel).  Including 1 mM SAM in the 
binding media significantly increased CSR ryanodine binding which was not 
blocked by SAH up to 1.8 mM or sinefingin up 3 mM.  Due to low solubility of 
SAH, higher concentrations of the compound were not used.  Importantly, neither 
SAH nor sinefungin alone significantly altered CSR ryanodine binding from 
control.  These results suggest activation of RyR2 by SAM is not the result of 
enzyme-mediated methylation 
 
3.4.3. RyR2 methylation is not detected following incubation of CSR vesicles 
with [3H]SAM 
  Additional experiments were performed to determine if RyR2 is 
methylated under conditions in which SAM activation of CSR [3H]ryanodine 
binding is observed.   CSR vesicles were pretreated with S-adenosyl-L-[methyl-
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3H]-methionine ([3H]SAM) in the presence or absence of SAH and/or excess 
unlabled SAM, followed by centrifugation and washing to remove unincorporated 
[3H]SAM. Radioactivity associated with pretreated CSR and retained in 
respective immunoprecipitates was determined as an indicator of methyl group 
incorporation (Table 2, Fig. 11 B).  The inset in Figure 11 B shows a 
representative Western blot as an indication of RyR2 protein yield obtained by 
our immunoprecipitation protocol. Inclusion of SAH and/or excess unlabled SAM 
in the incubation buffer during [3H]SAM treatment reduced the amount of 
radioactivity incorporated into CSR by ≥ 95%.  Less than 6% of the radioactivity 
incorporated into pretreated CSR was retained by immunoprecipitation, and was 
unaffected by inclusion of methyltransferase inhibitors in the incubation media.  
Furthermore, there was no difference in the amount of radioactivity recovered by 
immunoprecipitation performed in the presence or absence of a RyR2 specific 
antibody. RyR2, therefore, is not among the SR components methylated during 






Table 2. Scintillation counts from [3H]SAM pretreated CSR and 
Immunoprecipitated RyR2.  CSR was incubated as described in “Materials and 
Methods” Data are means ± SE from 3 experiments (all assays were performed in 
duplicate).  Significantly different from [3H]SAM alone  (* p ≤ 0.001, † p ≤ 0.01, 
# p ≤ 0.05). 
Incubation 
conditions 
CSR        
(CPM) 
 
RyR2 IP with 
antibody (CPM) 
RyR2 IP without 
antibody (CPM) 
[3H]SAM alone 54676 ± 4823 196.7 ± 37.12 175.17 ± 17.14 
+ unlabled SAM 1183 ± 92.26* 69.33 ± 25.39† 40.67 ± 11.08# 
+ SAH 2407 ± 299.5* 53.83 ± 13.57† 28.83 ± 3.77# 
+ unlabled SAM + 
SAH 








Figure 11. Methyltransferase inhibitors do not block SAM activation. (A) CSR 
vesicle ryanodine binding was performed as described in “Materials and 
Methods” in media containing 3 µM Ca2+, the indicated concentrations of 
sinefungin  (top panel; Bmax= 2.9 ± 0.2 pmol/mg;  n= 4) or S-adenosyl-l-
homocysteine (SAH) (bottom panel; Bmax= 2.5 ± 0.3 pmol/mg;  n= 4), with or 
without (No Addition) 1 mM SAM. [3H]Ryanodine binding is expressed as 
percent of maximal [3H]ryanodine binding. (B) CSR was incubated as described 
in “Materials and Methods” in the presence of 0.285 μM (3 μCi) [3H]SAM and 
No Addition or 1 mM SAH and/or 3.2 mM unlabled SAM (>1000 fold excess).  
CSR vesicles were centrifuged through sucrose, washed and resuspened 10% 
sucrose.  RyR2 was immunoprecipitated from treated CRS either in the presence 
or absence of anti-RyR,.  Liquid scintillation counting was used to measure 
radioactivity associated with 100 µg treated CSR (black bars), and 20 µl aliquots 
of samples immunoprecipitated from treated CSR in the presence (grey bars) or 
absence (white bars) of anti-RyR2. Inset shows a Western blot demonstrating 
typical protein yield from RyR2 immunoprecipitations performed as described in 
“Materials and Methods”. The position of RyR2 and RyR antibody are indicated 
with an arrow and asterisk respectively. Data are means ± SE from 3 experiments 




Figure 12.  Interaction between SAM and ATP activation of RyR2. CSR vesicle 
ryanodine binding was performed as described in “Materials and Methods” (A-C) 
and is expressed as a percent of maximal [3H]ryanodine binding.  (A) Effects of 
SAM on modulation of cardiac SR vesicle ryanodine binding by established 
RyR2 regulators.  Ryanodine binding was performed in media containing 3 µM 
Ca2+ in the presence or absence (control) of 1 mM AMPPNP or 1 mM Mg2+ with 
or without (No Addition) 1 mM SAM (Bmax = 1.5 ± 0.4 pmol/mg; n=  5).  
Significantly different from control (*p ≤ 0.001, # p ≤ 0.01). (B) Comparison of 
the SAM, AMPPNP, and ATP concentration dependence of CSR ryanodine 
binding performed in the presence of 3 µM Ca2+ (Bmax = 2.4 ± 0.3pmol/mg; n= 5).  
(C) Competition between the ADP and SAM or ATP induced increase in CSR 
ryanodine binding was performed in media containing 3 µM Ca2+ and the 
indicated concentrations of ADP with or without (No Addition) 0.6 mM ATP 
(Bmax = 3 ± 0.3pmol/mg; n=  4) (top panel) or 0.6 mM SAM (Bmax = 2.7 ± 0.15 
pmol/mg; n=  5) (bottom panel).  Significantly different from No Addition (*p ≤  







Figure 13.  Chemical structures of ATP, s-adenosyl-l-methionine (SAM), s-
adenosyl-l-homocysteine (SAH), and sinefungin.  SAM is synthesized from 
methionine and ATP, which serves as an adenosine “donor”.  Note the sulfonium 
of SAM imparts a net positive charge to the molecule in contrast to the 
electronegative phosphates of ATP.  The methyltransferase inhibitors SAH and 






 3.4.4. Effects of SAM on CSR vesicle ryanodine binding in the presence of 
other physiological RyR2 effectors 
  To further characterize SAM activation of RyR2 we investigated the 
effects of SAM on RyR2 regulation by Mg2+ and the non-hydrolyzable ATP 
analogue, AMPPNP (Fig. 12 A).  In the absence of other RyR2 regulators (3 µM 
Ca2+ alone) 1 mM SAM significantly increased CSR [3H]ryanodine binding over 
control from 17.0 ± 1.2% to 44.2 ± 4.1 % of maximal.  The addition of 1 mM 
Mg2+ to the binding media caused a reduction in CSR ryanodine binding both in 
the presence (23.8 ± 1.7%) and absence (1.1 ± 0.6%) of SAM.  CSR vesicle 
[3H]ryanodine binding was significantly enhanced by 1 mM AMPPNP to 38.3 ± 
1.7 % of maximal, however, in media containing 1 mM SAM, the addition of 
AMPPNP did not cause a further increase CSR ryanodine binding (48.6 ± 2.7%).  
Thus, SAM activation of RyR2 reduced channel activation by the ATP analogue 
AMPPNP. 
 
3.4.5. SAM competes with adenine nucleotide–induced increase in CSR vesicle 
ryanodine binding 
  Importantly, SAM contains an adenosine moiety, and is therefore 
structurally similar to ATP and other adenine based compounds (Fig. 13).  Thus, 
the interaction between SAM and AMPPNP activation of RyR2 provoked us to 
investigate more thoroughly whether SAM regulation of RyR2 results from SAM 
interacting with the adenine nucleotide binding site/s.  The substitution of 
AMPPNP for ATP avoids the potential confounding effect of RyR2 
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phosphorylation, however, differences in the efficacy of  RyR activation by ATP 
and its non-hydrolysable analogues have been noted (57, 60).  Thus, we compared 
the SAM, ATP, and AMPPNP concentration dependence of CSR vesicle 
ryanodine binding (Fig. 12 B).  The SAM and ATP concentration dependence of 
CSR [3H]ryanodine binding paralleled one another and did not plateau up to 10 
mM. Binding was significantly increased over control by all SAM concentrations 
≥ 0.1 mM and by all ATP concentrations ≥ 0.3 mM.  The extent of CSR 
[3H]ryanodine binding was not different between SAM and ATP at any of the 
concentrations investigated.  In contrast, the AMPPNP-induced increase in 
binding reached a plateau at ~2 mM.  The discrepancy between the ATP and 
AMPPNP concentration dependence of CSR ryanodine binding motivated the use 
of ATP in subsequent experiments.   
To determine whether there is an interaction between SAM and adenine 
nucleotide activation of RyR2, the ADP concentration dependence of CSR 
ryanodine binding was performed in the absence (No Addition) and presence of 
either 0.6 mM ATP or SAM.  In media containing 3 µM Ca2+, ADP increased 
CSR ryanodine binding in a concentration dependent manner and ATP enhanced 
binding in the absence and presence of 1 mM ADP, but had no further effect on 
binding at higher concentrations of ADP (Fig. 12 C, top panel).  The lack of an 
additive effect of ADP plus ATP is consistent with two ligands acting via a 
common site (the adenine nucleotide binding site/s).  Figure 12 C (bottom panel) 
shows that SAM enhanced CSR ryanodine binding in the absence and presence of 
1 mM ADP, but had no additional effect on binding in the presence of higher 
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concentrations of ADP. Taken together, the data presented in Figure 3 suggest 
that SAM and adenine nucleotides act through a common binding site.  
 
3.4.6. SAM activates RyR2 and increases sub-conductance level openings 
  As a more direct measure of SAM-induced channel opening we examined 
the effects of SAM on native RyR2 channels incorporated into phospholipid 
bilayers. Consistent with results from CSR ryanodine binding, 0.1 mM SAM 
activated RyR2, which was reflected by a significant increase in channel open 
probability (Po). In the experiment shown in Figure 14 channel Po increased from 
0.087 in the presence of 10 µM cis Ca2+ to 0.271 after the addition of 0.1 mM cis 
SAM. The increase in Po could be attributed to both an increase in the mean open 
time (Control = 0.45 ms; 0.1 mM SAM = 1.00 ms) and to a decrease in the mean 
closed time (Control = 6.35 ms; 0.1 mM SAM = 2.66 ms). The summary data 
presented in Table 3 and Figure 16 support the conclusion that 0.1 mM SAM 
caused a significant increase in mean open time.  Additionally, mean channel 
closed time was decreased in the presence of 0.1 mM SAM in 3 out of 4 




Figure 14. SAM activates native RyR2 channels. Currents were recorded in symmetrical 250 mM Cs+  
using a pulsing protocol consisting of steps to -70 mV.  Closed (C) and full conductance open (O) levels  
are indicated to the left of the traces and corresponding amplitude histograms from ≥ 2 min recording  
time are shown to the right.  Channel open probability (Po) is indicated above each trace.  The top trace 
 shows a representative channel activated by 10 μM cis Ca2+ and the bottom trace shows activity of the  











Figure 15. Comparison of SAM and ATP activation of native RyR2 channels.  
Currents were recorded in symmetrical 250 mM Cs+ using a pulsing protocol 
consisting of steps to -70 mV.  Closed (C), full conductance open (O) and sub-
conductance open (s) levels are indicated to the left of the traces and 
corresponding amplitude histograms from ≥ 2 min recording time are shown to 
the right.  Channel open probability (Po) is indicated above each trace.  Top traces 
in each panel show a representative channel activated by 10 μM cis Ca2+  and 
bottom traces show channel activity immediately following the addition of (A) 2 
mM cis ATP or (B) 2 mM cis SAM.  The SAM-induced sub-conductance state in 
B is typical and was observed in all experiments (6 single channel recordings) 
upon addition of 2 mM SAM, but was extremely rare upon the addition of 2 mM 
ATP. (C) Segments of channel recording following the addition of 2 mM cis 
SAM are shown on an expanded time scale. Transitions from the closed state (C) 
to the sub-conductance state (S and dotted line) and from the full conductance (O 
and solid line) to the sub-conductance state were frequently observed (arrows).  










To further investigate whether SAM interacts with the RyR2 adenine 
nucleotide binding site we compared the effects of SAM and ATP on the activity 
of native RyR2 channels.  An identical concentration of SAM and ATP shown to 
substantially activate RyR2 (2 mM) was chosen for comparison given the overlap 
in the SAM and ATP concentration dependence of CSR vesicle ryanodine binding 
(Fig. 12 B).   Activation of RyR2 was reflected by a significant increase in 
channel Po after the addition of either ATP or SAM to the cis chamber (Fig. 16 
A).   Representative RyR2 channel current recordings are shown in Figure 6. 
Channel Po increased from 0.0049 in the presence of 10 µM cis Ca2+ to 0.022 
after the addition of 2 mM cis ATP (Fig. 15 A). The increase in Po was due to an 
increase in the mean open time (Control = 0.94 ms; 2 mM ATP = 1.57 ms) and a 
decrease in the mean closed time (Control = 205 ms; 2 mM ATP = 96.8 ms).  
Although the channel shown in Figure 15 B was activated to a greater extent by 
Ca2+ alone (Po= 0.193) compared to the previous channel in A, the addition of 2 
mM cis SAM caused an immediate increase in Po to 0.290.  In contrast to ATP, 
however, SAM activation of RyR2 was associated with a marked change in 
channel conductance which is evident in the current trace and corresponding 
amplitude histogram (Fig. 15 B, bottom trace). Average maximal single RyR2 
channel unitary conductance (γmax) in 250 mM symmetrical Cs+ recorded at -70 
mV was 513 ± 10, 514 ± 15, 507 ± 16, 528 ± 28 pS for control, 0.1 mM SAM, 2 
mM SAM, and 2 mM ATP respectively.  The average conductance of sub-state 
openings in the presence of 2 mM SAM was 294 ± 22 pS corresponding to ~ 60% 
of γmax.  The summary data in Figure 16 B show that in the presence of 2 mM 
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SAM the percent of channel openings to a predominant sub-state ~ 60% γmax 
increased from 1.7 ± 1.2 to 31.3 ± 5%, while ATP had no effect on the percent of 
sub-state openings (control: 1.2 ± 0.5%; 2 mM ATP: 0.4 ± 0.2%).  Sub-states 
detected under control conditions likely reflect very brief openings that were not 
fully resolved. The percent of RyR2 sub-state openings also increased in the 
presence of 0.1 mM SAM (Control = 0.14 ± 0.08 %; 0.1 mM SAM = 1.54 ± 0.15 
% sub-state openings) (Fig. 16 B), however due to the low frequency of 
occurrence, these events are difficult to resolve visually (Fig. 14 A). RyR2 
channel transitions between the closed, maximum conductance, and the SAM-
induced sub-conductance state are more clearly resolved in segments of channel 
recording shown on an expanded time scale (Fig. 15 C).  In the presence of 2 mM 
cis SAM, entry into the sub-conductance state occurred either from the closed or 
from the fully open state. Both of these transitions were commonly observed 
(arrows in Fig. 15 C).  In agreement with previously described effects of ATP on 
RyR2 (43), single channel data indicate that 2 mM cis ATP enhanced channel Po 
through both an increase in mean open time and a decrease in mean closed time. 
In the representative single channel experiment shown in Figure 6 A, mean 
channel open time increased from 0.94 to 1.57 ms and mean closed time 
decreased from 205 to 96.8 ms after the addition of 2 mM cis ATP.  For the 
channel shown in Figure 14, 0.1 mM SAM increased the mean open time from 
0.45 to 1.00 ms and decreased the mean closed time from 6.35 to 2.66 ms. After 
the addition of 2 mM cis SAM (Fig. 15 B) mean channel open time increased 
from 0.919 to 3.13 ms and mean closed time decreased from 4.1 to 1.45 ms.  
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Thus, the effects of 0.1 mM and 2 mM SAM on RyR2 mean open and closed 
times followed similar trends to those observed for ATP (Table 2, Fig. 16 C-E).   
 
3.4.7. Potential Mechanisms of the SAM-induced sub-conductance state  
 Attempts were made to remove SAM by perfusion of the cis chamber, 
however, this procedure produced inconsistent results including substantial 
increases and declines in channel Po.  Thus, as an alternative approach to test the 
reversibility of the SAM-induced RyR2 sub-state we performed a subset of 
experiments in which native RyR2 from SAM treated heavy CSR were 
incorporated into phospholipid bilayers. Representative current recordings from 
these experiments are shown in Figure 8. Prior incubation with 2 mM SAM 
altered RyR2 conductance with 5 out of 7 channel recordings exhibiting a 
predominant sub-state of ~ 60% γmax (Fig. 17 B). This predominant sub-state was 
not observed in any channel recordings (5 recordings) from CSR incubated in the 
absence of SAM (Fig. 17 A), thus suggesting SAM alters RyR2 conductance via 
an indirect mechanism.   In a previous study, Chen and colleagues proposed that 
SAM activation of RyRs from smooth muscle occurs via dissociation of FKBP 
(124).  We therefore investigated whether SAM induced the dissociation of 
FKBP12.6 from the channel. After pretreatment of CSR vesicles with SAM (0, 
0.1 or 2 mM) at 37ºC for 30 min, the amount of FKBP12.6 associated with CSR 
vesicles was visualized by Western blots of CSR proteins immunostained with 
RyR2 or FKBP12.6 specific antibodies (Fig. 18 B, top panel).  Immunostaining of 
the FKBP12.6 band (~12 kDa) was not reduced by incubation of CSR with 0.1 or 
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2 mM SAM.  We also investigated whether the association between FKBP12.6 
and RyR2 was required for the SAM-induced increase in CSR vesicle ryanodine 
binding.  For this purpose, CSR vesicles were incubated in the absence (No 
addition) or presence of FK506, an immunosuppressant which has been show to 
cause dissociation of FKBPs from RyRs (143).  FK506 treatment did not affect 
the SAM concentration dependent increase in CSR ryanodine binding (Fig. 18 B, 
bottom panel), further supporting the conclusion that FKBP12.6 dissociation is 
not the mechanism underlying SAM regulation of RyR2. We therefore envision 
that SAM reduces channel conductance by causing a conformational change in 















Table 3.  Effects of ATP and SAM on mean channel open and closed times.  Single RyR2 channel 
currents were recorded in the presence of 10 µM cis Ca2+ and analyzed for mean open and closed  
times as described in “Materials and Methods” before and after the addition of 2 mM ATP, 2 mM SAM,  






different from mean open time before addition (* p ≤ 0.05). 
 Mean open time 
Before addition 
(ms) 
Mean open time 
After addition 
(ms) 
Mean closed time 
Before addition 
(ms) 
Mean closed time 
After addition  
(ms) 
2 mM ATP  0.73 ± 0.16 1.32 ± 0.33 87.77 ± 58.65 36.13 ± 30.39 
2 mM SAM 0.86 ± 0.10 2.47 ± 0.82 28.17 ± 19.11 6.13 ± 3.33 
0.1 mM SAM 0.57 ± 0.11 1.12 ± 0.20* 6.73 ± 2.44 2.89 ± 1.23 
 
Figure 16. Effects of SAM and ATP on RyR2 activation and conductance.  RyR2 
channel currents were recorded in the presence of 10 µM cis Ca2+ (control) and 
following the addition of the indicated concentrations of cis ATP or SAM and 
analyzed as described in “Materials and Methods” for the following parameters:  
(A) Channel Po (n = 6-12), (B) single RyR2 % sub-state opening (n = 4-5), and 
(C-E) single RyR2 mean open and closed times (n = 4). Significantly different from 






Figure 17.  RyR2 from SAM treated CSR exhibit altered conductance.  Native RyR2 from heavy  
CSR incubated as described in “Materials and Methods” in the (A) absence or (B) presence of  
2 mM SAM were incorporated into phospolipid bilayers.  Currents were recorded in symmetrical  
250 mM Cs+ using a pulsing protocol consisting of steps to -70 mV.  Closed (C), full conductance  
open (O) and sub-conductance open (s) levels are indicated to the left of the traces and corresponding  
amplitude histograms from ≥ 2 min recording time are shown to the right.  Channel open probability  




Figure 18.  FKBP12.6 dissociation does not underlie the SAM related RyR2 sub-
conductance state.  (A) CSR vesicles were incubated as described in “Materials 
and Methods” in the presence of 0, 0.1, or 2 mM SAM.  Treated CSR vesicles 
were centrifuged through 15% sucrose, washed, and resuspended in a minimal 
volume of 10% sucrose. CSR was subjected to SDS-PAGE followed by Western 
blot analysis using antibodies specific for RyR2 and FKBP12.6. Western blot 
analysis indicates that SAM did not induce the loss of FKBP12.6 from CSR.  
CSR vesicles were treated with or without 10 µM FK506, pelleted, washed, and 
resuspended in a minimal volume of buffer.  (B) Ryanodine binding to pretreated 
CSR was performed as described under “Materials and Methods” in media 
containing 10 µM Ca2+ and the indicated concentration of SAM.  [3H]Ryanodine 
binding is expressed as a percent of maximal [3H]ryanodine binding (Bmax=  2.3 ±  
0.4; n= 4). FKBP506 treatment did not alter the SAM-dependence of CSR 





 Using CSR ryanodine binding and RyR2 current recordings we have shown that 
SAM activates RyR2. SAM participates in methylation of proteins and other 
macromolecules, a mechanism by which the localization and function of biological 
targets is altered (2).  A diverse class of enzymes known as methyltransferases catalyzes 
the transfer of the methyl group from the sulfonium of SAM to the oxygen, nitrogen, or 
sulfur atom of biological targets (3).  We therefore investigated whether SAM activation 
of RyR2 is associated with channel methylation by incubation of CSR vesicles with SAM 
containing a radiolabled methyl group.  Inclusion of the methyltransferase inhibitor SAH 
and/or excess unlabled SAM in the incubation buffer reduced the amount of radioactivity 
incorporated into CSR vesicles by ≥ 95% indicating (i) methyltransferases are present in 
our CSR preparations, and (ii) SAM provides methyl groups for methylation of CSR 
components. However, immunoprecipitation of RyR2 from solubilized [3H]SAM treated 
CSR showed that the amount of radioactivity associated with RyR2 was negligible and 
nonspecific given that no difference was found compared to samples from 
immunoprecipitations performed in the absence of an RyR2 specific antibody (Table 2, 
Fig. 11 B). Furthermore, inclusion of the methyltransferase inhibitors SAH or sinefungin 
in the binding media did not prevent the SAM-induced increase in CSR ryanodine 
binding (Fig. 11 A).  Together these data suggest SAM activation of RyR2 does not 
involve channel methylation.   
A point of interest is the structural similarity between SAM and ATP (Fig. 13), an 
important physiological regulator of RyR2.  Like ATP and its non-hydrolysable analogue 
AMPPNP, SAM contains an adenosine moiety raising the possibility that SAM regulates 
91 
RyR2 via the adenine nucleotide binding site/s. Using CSR ryanodine binding we found 
that SAM reduced the extent to which AMPPNP activated RyR2 (Fig. 12 A).  
Competition experiments were designed to further investigate the interaction between 
SAM and adenine nucleotide activation of RyR2.  The combined effects of ADP and 
ATP on CSR ryanodine binding were not additive, in line with the expectation for two 
ligands acting through a common binding site.  Likewise, ADP and SAM did not exert 
additive effects on CSR ryanodine binding (Fig. 12 C), suggesting that SAM acts through 
binding either the RyR2 adenine nucleotide binding site or a distinct but interacting site 
on the channel.   
Single channel current recordings and analysis are routinely used to clarify the 
mechanisms underlying channel regulation.  A principal goal of the present study, 
therefore, was to compare the affects of SAM and ATP on RyR2 channel gating using 
native RyR2 incorporated into phospholipid bilayers.  In addition to 0.1 mM SAM, we 
chose a higher concentration of SAM and ATP (2 mM) shown though ryanodine binding 
to produce substantial activation of RyR2 (Fig. 12 B). Single channel analyses showed 
that the effects of SAM on RyR2 Po, mean open, and closed times followed similar trends 
to those observed for ATP (Table 3, Fig. 16 C-E).  However, unlike ATP, SAM affected 
RyR2 channel conductance.  A concentration dependent increase in the proportion of 
channel openings to a sub-conductance level ~ 60% γmax was observed in the presence of 
0.1 mM and 2 mM SAM (Fig. 16 B), with a much more pronounced effect observed with 
2 mM SAM.  
Interestingly, we observed that prior incubation of CSR with SAM caused lasting 
effects on RyR2 conductance while identical treatment of CSR in the absence of SAM 
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was without effect (Fig. 18).  In these experiments, a wash step was included to remove 
SAM prior to channel incorporation thus, an indirect mechanism distinct from ligand 
binding likely underlies the SAM induced RyR2 sub-state.  In its native membrane the 
RyR2 is part of a macromolecular complex in association with a number of accessory 
proteins implicated in channel modulation, and signaling molecules involved in 
posttranslational protein modification (99).  It is plausible that SAM alters the interaction 
between RyR2 and one or more endogenous effector proteins thereby affecting channel 
conductance. The RyR accessory protein FKBP12/12.6 is associated with RyRs in a 4:1 
ratio with one FKBP bound to each RyR monomer. Removal of FKBP12 from the 
skeletal isoform of the channel (RyR1) increases channel activity, and is associated with 
an increased frequency of sub-conductance openings (82, 141).  However, whether 
removal of FKBPs from RyR2 results in a similar alteration of channel behavior is 
unclear (22, 52).  Chen and colleagues attributed SAM activation of smooth muscle RyRs 
to FKBP methylation causing its dissociation from the channel (124).  In an attempt to 
determine whether FKBP dissociation is involved in the SAM related RyR2 sub-
conductance state we performed Western blot analysis of CSR proteins and found that 
immunostaining of the FKBP12.6 band was not reduced by incubation of CSR with 0.1 
or 2 mM SAM (Fig. 17 B, top panel).  In addition there was no difference in the SAM-
induced increase in ryanodine binding to FK506 treated (FKBP stripped) and control 
CSR (Fig. 17 B, bottom panel). 
The ability of ATP and its metabolites to activate RyR2 (efficacy) decreases in the 
order ATP > ADP > AMP > adenine > adenosine (43, 62). Although the purine ring is 
important for agonist activity (57), the structural features of adenosine based compounds 
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which impart efficacy in activating RyR2 are unknown. Several lines of evidence suggest 
SAM activates RyR2 via the adenine nucleotide binding site/s: (i) SAM contains an 
adenosine group, (ii) RyR2 activation by SAM and adenine nucleotides is similar in that 
both compounds enhance Ca2+ activation of the channel but have minimal effects on 
channel activity in the absence of Ca2+ (57), (iii) the SAM and ATP concentration 
dependence of CSR ryanodine binding overlap, (iv) SAM and adenine nucleotides have 
non-additive effects on CSR ryanodine binding, and (v) SAM and ATP have similar 
effects on mean channel open and closed times.  
Studies using native RyR2 channels in phospholipid bilayers have demonstrated that 
decreasing the number of phosphate groups decreased the ability of adenosine based 
compounds to activate the channel (43, 62).  Additional research has used comparative 
molecular field analysis to correlate the chemical structure of adenosine based molecules 
with their ability to activate RyR2.  This work showed that changes in electrostatic field 
and steric factors account for 64%, and 36%, respectively, of the total correlation 
between structure and function. Increasing positive electrostatic potential of the molecule 
in diffuse regions corresponding to the phosphate groups of ATP was strongly correlated 
with increasing Po, meanwhile, increasing negative electrostatic potential distal to the γ 
phosphate was correlated with increasing Po.  Thus, the effect of electrostatic field on the 
conformational state of RyR2 is apparently complex.  Nevertheless, the high efficacy of 
ATP was primarily attributed to the negative electrostatic field established by its ionized 
phosphate groups (61).  SAM contains a positively charged sulfonium located in the 
region of the molecule corresponding to the α phosphate in ATP (Fig. 13), yet is equally 
effective as ATP in activating RyR2. Therefore, our proposal that SAM activates RyR2 
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via the adenine nucleotide binding site challenges the interpretation that high ligand 
efficacy at the adenine nucleotide site/s requires a negative electrostatic potential. The 
methyltransferase inhibitors used in this study (sinefungin and SAH) are adenosine based 
compounds which have no net charge (Fig. 13). Neither sinefungin nor SAH had an 
effect on RyR2 activity (Fig. 11 A), an observation which is in accord with an important 
role of electrostatic interactions in the process of nucleotide activation of RyR2.  Our data 
shed new light on the structure-activity relationship underlying adenine nucleotide 
regulation of RyR2 and suggest a potential use of SAM as a tool to clarify the structural 
basis for ligand affinity and efficay at the adenine nucleotide site/s.   
Interventions to increase intracellular SAM concentrations were shown to have a 
positive ionotropic effect in the heart which was at least partially attributed to activation 
of the SR Ca2+ pump (SERCA) upon SAM-dependent N-methylation of membrane 
phospholipids (122, 144). Indeed, investigations of the effect phospholipid N-methylation 
has on RyR2 activity are lacking, however, the observed inability of methyltransferase 
inhibitors to block the SAM induced increase in CSR ryanodine binding suggests 
methyltransferase activity, and thus methylation, is not involved in SAM activation of 
RyR2.  The virtual overlap in the SAM and ATP concentration dependence of CSR 
[3H]ryanodine binding indicates that both the affinity of SAM for RyR2 and its ability to 
open the channel are comparable to that of ATP.  Therefore, if SAM acts through binding 
the adenine nucleotide site/s on RyR2, SAM would not function as an effective channel 
agonist given that cytosolic levels of ATP in cardiac cells (5-10 mM) (59) far exceed 
cellular concentrations of SAM (60-90 μM) (112).  Our data suggest SAM acts via an 
indirect yet undetermined mechanism to reduce channel conductance, however, the 
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functional implication of sub-states in RyRs is unknown, therefore the role of SAM as a 
physiological regulator of RyR2 is uncertain.    
Considering the present data, multiple mechanisms are suggested to account for the 
effects of SAM on RyR2 activation and conductance.  We propose SAM activation of 
RyR2 results from a direct interaction with the channel, most likely binding the adenine 
nucleotide site/s. The observed effect of SAM on RyR2 conductance presumably occurs 
via an indirect mechanism in which SAM reduces channel conductance by causing a 
conformational change in the RyR2 protein. Such an effect may result from the SAM 
induced loss of an undetermined RyR2 accessory protein.   Determining the mechanism 
by which SAM causes RyR2 sub-states will further our understanding of the biophysical 
properties of RyR2 regulation.  
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CHAPTER 4 
INSIGHTS INTO S-ADENOSYL-L-METHIONINE REGULATION OF 
CARDIAC RYANODINE RECEPTORS: EVIDENCE FOR AN ALLOSTERIC 
MECHANISM OF SUBSTATE PRODUCTION 
 
4.1. Abstract 
S-adenosyl-l-methionine (SAM) can act as a RyR2 channel regulatory ligand in a manner 
independent from its recognized role as a biological methyl group donor.  Channel 
activation appears to arise from the direct interaction of SAM, via its adenosly moiety, 
with the RyR2 adenine nucleotide binding sites.  In addition to its ability to activate 
RyR2, recent single channel experiments revealed distinct effects of SAM on RyR2 
conductance, which we now explore in greater detail.  The effects of SAM on channel 
conductance are dependent on SAM concentration and membrane holding potential.  At 
negative potentials, cis applied SAM induces a clearly resolved subconductance state.  
The proportion of SAM induced subconductance openings (Psub/Po), expressed as a 
proportion of overall channel open probability, increases with decreasing negative 
potential.  Kinetic analysis revealed that changes in the off rate fully accounted for the 
voltage dependence of the transitions between the full open state and the SAM induced 
subconductance state. However, at positive potentials SAM causes a striking reduction in 
channel openings with no distinct effect on channel conductance.  Inconsistent with a 
simple pore block mechanism is the finding that that prevalence of the subconductance 
state is unaffected by varying the driving force for ion flux.  Furthermore, ATP is able to 
specifically interfere with the effects of SAM at both negative and positive potentials 
suggesting competition with SAM for a common binding site.  Our experimental findings 
are interpreted in light of an allosteric mechanism whereby SAM interacts with the RyR2 
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adenine nucleotide binding site.  SAM binds to and allosterically stabilizes a channel 
conformation of reduced conductance and we propose the voltage dependence of the 
SAM induced subconductance state arises from a voltage-driven alteration in the affinity 
of the adenine nucleotide binding sites for SAM. 
 
4.2. Introduction 
The ryanodine receptor (RyR) is a large homotetrameric intracellular ion channel which 
mediates the release of Ca2+ from the sarcoplasmic reticulum (SR) or other intracellular 
stores.  The subcellular Ca2+ signaling which underlies the beat to beat contraction of the 
heart is regulated through a process of Ca2+-induced-Ca2+ release (CICR).  Importantly, 
the basis of CICR regulation is the sensitivity of the cardiac isoform of the Ca2+ release 
channel (RyR2).  Although Ca2+ is the primary physiological channel activator, alone it is 
unable to fully activate RyR2 (59).  
 The Ca2+ sensitivity of RyR2 is influenced by a number of endogenous effectors 
including adenine nucleotides. Electron paramagnetic resonance studies have suggested 
that per RyR monomer, there are two adenine nucleotide binding sites whose availability 
is altered with conformational changes in the channel protein (63, 145).  Among these 
nucleotides, adenosine triphosphate (ATP) is the most potent channel activator (43, 62).  
Although the importance of the purine ring for agonist activity is recognized (57), other 
structural features that influence the efficacy of adenine nucleotides are poorly defined.  
 S-adenosyl-l-methionine (SAM) is produced when the adenosyl moiety from 
adenosine triphosphate (ATP) is transferred to methionine forming a sulfonium which 
readily donates its methyl group through enzyme (methyltransferase) dependent reactions 
 98
to numerous biological substrates (112, 117, 138).  The RyR modulating effects of SAM 
were first described by Chen and colleagues, who attributed SAM activation of RyRs 
from coronary artery myocytes to protein methylation and subsequent dissociation of the 
RyR accessory protein FKBP12 (124).  However, we have shown that SAM activates a 
defined channel isoform, RyR2, via a direct physical interaction with a regulatory site on 
the channel (137, 146).  Furthermore, observed similarities between SAM- and ATP- 
enhancement of CSR ryanodine binding, and competition between SAM and adenine 
nucleotides suggest that this regulatory site is shared by SAM and ATP.  In single 
channel experiments we also observed a previously unreported SAM related 
subconductance state which could not be attributed to FKBP dissociation (146). 
Subconductance events have been characterized in a variety of both voltage- and ligand-
gated ion channels. Although in some cases, such as the GABA- and glycine-activated 
chloride channels, these subconductance events are intrinsic characteristics of the channel 
(78), many endogenous and exogenous compounds induce channel subconductance 
events. The mechanisms by which channel effectors induce subconductance levels can 
broadly be classified as those that interact with the channel conduction pathway (i.e. pore 
block) or allosteric modulators. The compounds that interact with the channel pore 
interfere with flux of the conducting ions through the channel. In contrast, allosteric 
modulators, which may bind some distance from the channel conducting pathway, either 
induce or stabilize a channel conformation that limits the flux of ions through the pore. 
Various exogenous RyR regulators modulate channel conductance by producing a 
voltage dependent reduction in the amplitude of the open full conductance state, or 
producing one or multiple subconductance states. Ryanoids, and various peptide toxins 
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(e.g. IpTxa) are proposed to allosterically limit channel conductance, producing a voltage 
dependent subconductance state upon the binding and stabilization of a distinct protein 
conformation (allosteric mechanism) (93, 107).  In contrast, the behavior of a voltage 
dependent RyR2 subconductance state produced by the tetra butyl ammonium cation 
(TBA+) is more consistent with a pore block mechanism whereby TBA+ interacts with 
permeant ions (86).  
 This work clarifies the mechanism by which SAM promotes a subconductance 
state in RyR2.  We find that the voltage dependence and kinetics of SAM interaction are 
inconsistent with a simple pore block mechanism.  Furthermore, premeant cations (Cs+) 
do not interfere with the SAM related substate, indicating that SAM affects channel 
conductance through a regulatory (i.e. allosteric) site located on the cytosolic face of 
RyR2 some distance from the permeation pathway.  We also report a specific interaction 
between SAM and ATP observed at the single channel level; a strong indication that 
SAM and ATP bind a common regulatory site.  Our results are consistent with an 
allosteric model whereby SAM binds to and stabilizes a voltage dependent 
subconductance conformation of the RyR2 channel.  To account for the voltage 
dependence of the SAM related substate we propose a voltage driven change in protein 
conformation alters the affinity of a regulatory site for SAM.  In our model we attribute 
the interaction between SAM and ATP to their binding a common adenine nucleotide 





4.3. Materials and methods 
 
4.3.1. Materials 
 Pigs were purchased from Clemson University Research Farm Services.  S-(5’-
adenosyl)-L-methionine chloride (SAM), S-(5’-adenosyl)-L-homocysteine (SAH), 
sinefungin, ATP, 4-chloro-m-cresnol (4-CmC) and tetrabutrylammonium bromide (TBA) 
were obtained from Sigma Aldrich (St. Louis, MO).  Phospholipids were purchased from 
Avanti Polar Lipids (Alabaster, AL). 
 
4.3.2. Isolation of cardiac sarcoplasmic reticulum vesicles 
 Non-pietrain pigs were euthanized in accordance with the Public Health Services 
Policy on Humane Care and Use of Laboratory Animals and with the approval of the 
Institutional Care and Use Committee of the Georgia Institute of Technology. Briefly, 
following sedation by subcutaneous injection of ketamine (20 mg/kg) and xylazine (2 
mg/kg) animals were euthanized by intravenous injection of sodium pentobarbital (100 
mg/kg). Heavy CSR vesicles were isolated based on the method of Sitsapesan and 
Williams (16).  Ventricular and septal muscle was cleaned of excess fat and connective 
tissue, minced and homogenized in an ice-cold buffer containing 300 mM sucrose, and 
20 mM piperazine-N,N’-bis(2-ethanesulfonic acid) (PIPES) (pH 7.4), centrifuged at 
10,000 × g. The retained supernatant was centrifuged a second time at 87,000 × g and the 
pelleted  membranes were resuspended in a salt solution (400 mM KCl, 0.5 mM MgCl2, 
0.5 mM CaCl2, 0.5 mM EGTA, 25 mM PIPES, pH 7.0)  containing 10% sucrose w/v. 
The mixed membrane suspension was layered upon discontinuous sucrose-density 
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gradients consisting of identical salt solutions containing 20%, 30%, and 40% sucrose 
w/v and sedimented at 100,000 × g.  Heavy CSR membrane vesicles collected at the 30-
40% sucrose interface were diluted in 400 mM KCl, pelleted at 87,000 × g, and 
resuspended in a minimal volume of buffer containing 400 mM sucrose, and 5 mM 4-(2-
hydroxyethyl)-1-iperazineethanesulfonic acid (HEPES) (pH 7.2).  All steps were 
performed at 4oC and isolation buffers contained a mixture of protease inhibitors 
(aprotinin, leupeptin, pepstatin A, benzamidine, and phenylmethylsulphonyl-fluoride). 
Vesicles were frozen rapidly in liquid N2 and stored at -80ºC.   
 
4.3.3. Single channel recordings 
 Muller-Rudin bilayers were formed by painting a lipid mixture 
(phosphatidylethanolamine, phosphatidylserine, phosphatidylcholine, 5:3:2 ratio by wt, 
50 mg/ml dissolved in n-decane) across a 100 - 250 μm aperture in a Delrin cup.  To 
assist in vesicle fusion, an osmotic gradient was established across the bilayer and the cis 
chamber was stirred.  Heavy CSR vesicles were added to the cis chamber which 
contained 250 mM cesium methanesulfonate, 10 mM HEPES (pH 7.4), and 1 mM CaCl2.  
The trans chamber contained 50 mM cesium methansulfonate and 10 mM HEPES pH 
7.4. After incorporation of channels into the bilayer, the osmotic gradient was abolished 
by raising the concentration of cesium methansulfonate in the trans chamber to 250 mM 
and the cis chamber Ca2+ concentration adjusted by adding small aliquots of concentrated 
EGTA and CaCl2 (21). Small aliquots of concentrated channel regulators were added to 
the cis chamber with stirring prior to data acquisition. Voltage was controlled and 
channel currents were recorded using an Axoclamp 200B patch clamp amplifier 
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(Molecular Devices). The cis and trans chambers were connected to the amplifier head 
stage by Ag/AgCl electrodes and agar salt bridges.  In our experimental setup current is 
applied to the cis chamber with the trans chamber held at ground.  Therefore in 
symmetrical cesium methansulfonate a negative membrane potential promotes the flow 
of Cs+ from trans to cis.  Current was monitored on an oscilloscope, recorded at 5 kHz 
and signals were filtered at 1 kHz.  Channel data were collected using a pulsing protocol 
in which the potential was held at 0 mV for 120 ms between steps of 2-s  duration each to 
-50 and + 50 mV (CLAMPEX program, pCLAMP 9.2 software, Molecular Devices, 
Sunnyvale, CA).   
 
4.3.4. Analysis of data 
 Single-channel events indicated by current transitions between the closed (c), 
open subconductance (s), and open full conductance (o) levels were measured from 
digitized data using manually controlled cursors. Channel activity from at least 30 sweeps 
was analyzed using the Clampfit program (pCLAMP9.2 software).  Open probabilities 
and lifetimes of closed and open events were determined using the method of 50% 
threshold analysis. To avoid the complication that subconductance events may arise from 
unresolved brief channel openings, events shorter than 1.0 ms (3 times the filter rise time) 
were excluded from analysis. This is a more conservative cut-off than typically 
employed, but ensured that the amplitude of the filtered events reached >99.8% of the 
true events(147).  All channel openings, to either the open full conductance or open 
subconductance level were included in the determination of Po.  Normalized all points 
current amplitude histograms (band width = 1 pA) were attained from each 2-minute 
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recording. In most experiments, components corresponding to the baseline, full open and 
in the presence of SAM, subconductance currents were readily identified. Each 
component was fit with a Gaussian function using the Levenberg-Marquardt method.  
Prevalence of the SAM induced subconductance state was measured by setting two 
thresholds, one at the subconductance level, and a second at the conductance level.  
Prevalence of the subconductance state, (Psub/Po), was calculated by dividing the open 
probability of subconductance state (Psub) by overall channel open probability (Po), which 
included openings to both the open full conductance level and the open subconductance 
level.  Lifetime analysis was carried out only when a single channel incorporated into the 
bilayer. Closed, open full conductance, and open subconductance lifetimes were fitted to 
a probability density function (PDF) by the method of maximum likelihood according to 
the equation 
 
f(t) = a1 exp (-t/τ1) + … + an exp (-t/ τn)                                                                       (1) 
 
where a is the area or fractional contribution for that component to the area under the 
curve, τ is the time constant, an estimate of the mean dwell time of that component, and t 
is the dwell time.  Fits of up to three exponentials were compared by testing the 
difference in the log (likelihood) against the chi-squared distribution at the 5% level.  
Analysis of the voltage dependence of the transitions between the open subconductance 
state and the open full conductance state was based on the assumption that theses 
transitions arise from the association and dissociation of SAM from the channel.  For this 
purpose, all closed events, and all open events preceded or succeeded by a closed event, 
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were excluded from analysis using code developed in MATLAB.  The rates for SAM 
association (kon) and dissociation (koff) were derived from single exponential fits to dwell 
time distributions of the open full conductance and open subconductance states 
respectively.  The SAM concentrations of half maximal efficacy were determined using 
non-linear curve fitting of Eq. (2) to dose response relationships for Po and Psub/Po  
 
y = (BBmax × [SAM])/ (Kd + [SAM])       (2) 
 




Single channel open probabilities (Po), prevalence of the subconductance state (Psub/Po), 
and dwell times are presented as means ± SEM analyzed using Student’s paired t-tests.  
Statistical analysis was performed using SigmaStat 3.1 (Systat Software, Point 




4.4.1. SAM differentially affects RyR2 at positive and negative potentials 
 Under control conditions (10 µM Ca2+) channel open probability (Po) was 
0.431±0.052 at +50 mV and 0.439±0.069 at -50 mV. Channels had a slope conductance 
of 441± 13 pS (Fig.19). Current reversed at -4.8 mV. The non-zero reversal potential was 
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likely due to the mixing of chamber solutions upon repeated breakage and reformation of 
the bilayer prior to successful channel incorporation.   
Initial experiments investigated the effect of SAM on single channel currents in lipid 
bilayers using a sequential pulsing protocol to -50 and +50 mV.  Channel activity was 
better maintained using this alternating voltage protocol compared to a protocol 
consisting of steps to positive or negative voltages alone.  In previous work 2 mM SAM 
was shown to promote a single, clearly resolved subconductance state, while a lower 
concentration of SAM (0.1 mM) was relatively ineffective at promoting the substate 
(146).  For the purpose of clarifying the mechanism by which SAM affects channel 
conductance, 2 mM SAM was chosen as it unambiguously promoted the effect of interest 
(i.e. the subconductance state).  Interestingly, membrane potential significantly altered 
channel response to SAM.  The current traces to the left in Figure 20A show channel 
activity recoded at a holding potential of -50 mV, before and immediately after the 
addition of 2 mM SAM to the cytosolic chamber (cis SAM).  At -50 mV, SAM increased 
channel Po to 0.824±0.055 and caused a dramatic increase in the appearance of a single 
clearly resolved subconductance state (~2/3 full conductance) as previously reported 
(146). Channel Po increased as SAM concentration was increased from 0.3 mM to 10 
mM.  The dose response curve in the top panel of Figure 21 plateaus around 2 mM SAM 
and gives a half maximal effective SAM concentration (Kd) of 0.11±0.11 mM.  In 
contrast, at a holding potential of +50 mV, channel Po decreased exponentially with 
increasing concentrations of SAM (Fig. 21, bottom panel).  Two mM cis SAM decreased 
channel Po to 0.010±0.002 and did not promote a subconductance state (Fig. 20A, right).  
None of the SAM concentrations investigated effectively promoted a subconductance 
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state at positive potentials.  For example, 0.3 mM SAM which caused a more moderate 
(~50%) reduction in channel Po, had no noticeable effect on channel conductance.  Due to 
the strong inhibitory effect of SAM at positive potentials, channel analysis was primarily 
limited to recordings at negative holding potentials.       
The prevalence of the SAM related substate, expressed as the fraction of open 
time the channel spent in the subconductance state (Psub/Po) increased from 0.111±0.019 
in the absence of SAM to 0.632±0.050 in 2 mM SAM (Fig. 20 A, left).  In contrast to the 
SAM concentration dependence of overall channel open probability (Po) which saturated 
at 2 mM SAM (Fig. 21, top panel), Psub/Po continued to increase with SAM 
concentrations > 2 mM (Fig. 22A).   In the absence of SAM, a fraction of the substate 
events can be attributed to noise reaching the 50% threshold for the subconductance level 
and generating a false event. The false event rate is a function of the 50% threshold event 
amplitude (A), the root mean squared noise of the system in the absence of channel 
activity (σn) and the filter cut-off frequency (fc) according to equation 3 (147). 
 
false event rate ≈ fc exp[-0.5(A/ σn)2]       (3) 
 
At negative potentials where subconductance events were studied, the slope of the 
substate current-voltage relationship gave a slope conductance of 289±13 pS (Fig. 19).  
At a holding potential of -50 mV current amplitude of the subconductance state was ~ 
14.5 pA with 50% threshold of ~7.25 pA.  A σn of 2.5 pA and a fc of 1 kHz yields a false 
event rate of 15 events per sec.  In the absence of SAM the frequency of subconductance 
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events at -50 mV was 29±4.5, therefore false events accounted for approximately 52% of 
the subconductance events under control conditions.   
 In 4 out of 4 experiments, addition of 2 mM SAM to the luminal side (trans 
chamber) had no observable effect on channel conductance or open probability at + 50 
mV (control Po, 0.208 ± 0.105; trans SAM Po, 0.300 ± 0.177) or -50 mV (control Po, 
0.184 ± 0.1; trans SAM Po, 0.262 ± 0.158)  (Fig. 20 B).  The methyltransferase inhibitor 
sinefungin is a structural analogue of SAM, yet when applied to the cis chamber, 
sinefungin had no effect on channel activity at a holding potential of +50 mV (control 
Po,0.147 ± 0.097; sinefungin Po, 0.238 ± 0.063) or -50 mV (control Po, 0.213 ± 0.154; 







Figure 19. Current-voltage relationship of the maximum conductance and 
subconductance states.  Mean current values of the maximum full conductance state in 
the absence of SAM (○), maximum full conductance state in the presence of 1 mM SAM 
(●), and the subconductance state in the presence of 1 mM SAM (■).  Data points show 










Figure 20. SAM produces a subconductance state from the cytoplasmic face of the 
channel.  Single channel currents shown as downward or upward deflections from closed 
(c), were recorded in symmetrical 250 mM Cs+ using a pulsing protocol consisting of 
steps to ±50 mV.  Cytosolic free Ca2+ concentration was ~10 µM.  (A) A subconductance 
state (s) became prevalent following the addition of 2 mM cis SAM, but only when 
current is recorded at a negative holding potential (HP=-50 mV).  At a positive potential 
(HP = +50 mV) 2 mM SAM nearly abolished channel activity.  The effects of SAM were 
observed immediately after ~ 10 sec of chamber stirring. (B) SAM had no effect on 
channel activity when added to the trans chamber. (C) Sinefungin, a structural analogue 





Figure 21. SAM differentially affects channel open probability at negative and positive 
potentials. At a negative potential of -50 mV, Po increased with increasing SAM 
concentration (top panel), whereas at +50 mV, Po decreased exponentially with 
increasing SAM concentration (bottom panel).   Data points show the means ± SEM of 1-
3 experiments. The dose response at -50 mV was fit to a one site saturation ligand 
binding equation (y = Bmax×/Kd+×) with parameter values Bmax = 1.70±0.149, and Kd = 
0.111±0.111.  The dose response at +50 mV was fit with an equation for exponential 






Figure 22. Voltage and SAM concentration dependence of the subconductance state. (A) 
The proportion of subconductance events (Psub/Po) observed at -50 mV increased with 
SAM concentration.  The dose response was fit to a one site saturation ligand binding 
equation (Bmax = 0.915±0.070, and Kd = 0.887±0.231).  Data points show the mean ± 
SEM from 1-3 experiments. (B) The proportion of subconductance events (Psub/Po) 
increased as holding potential became less negative.  Data points show the mean ± SEM 




4.4.2. The subconductance state is dependent on SAM concentration  
 Figure 19 shows that the linear current-voltage relationship of the open full 
conductance state was not altered by SAM (no SAM, slope conductance = 441±13 pS; 1 
mM SAM, slope conductance = 428±4 pS).  The rarity of events in the presence of SAM 
at positive potentials makes the conductance measurements here less reliable than at 
negative potentials. Considering channel openings only at negative potentials yields a 
substate slope conductance of 289±13 pS, approximately 2/3 full conductance.  The dose 
response curve in Figure 22A shows that the prevalence of the SAM related substate 
(Psub/Po) increased with SAM concentration.  Equation 2 fit to the SAM dose response 
curve gives a half maximal effective SAM concentration of 0.887±0.231 mM, and a 
maximum Psub/Po value of 0.915±0.07.  The prevalence of the SAM related substate was 
independent of overall channel Po. 
 
4.4.3. Behavior of the subconductance state is inconsistent with a simple pore block 
mechanism  
  SAM was only effective at producing the subconductance state at negative 
potentials which promote the trans to cis flux of Cs+ and therefore do not favor entry of 
SAM into the conductance pathway. The prevalence of the SAM related substate 
increased as holding potential was decreased from -75 to -25 mV (in 25 mV increments).  
In Figure 22 B Psub/Po, in the presence of 2 mM cis SAM is plotted as a function of 
applied negative potential.  Psub/Po increased from 0.284 ± 0.224 at a holding potential of 
-75 mV to 0.487 ± 0.128 and 0.718 ± 0.13 at -50 mV and -25 mV respectively.  The pore 
block hypothesis attributes the effect of SAM on channel conductance to SAM entering 
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the conductance pathway thereby directly interfering with the translocation of Cs+.   
Based on this hypothesis, the SAM related substate is expected to be sensitive to changes 
in the driving force for Cs+ flux through the channel, due to competition between Cs+ 
ions and SAM within the conductance pathway.  Therefore, Psub/Po is expected to 
decrease as the concentration gradient for Cs+ is increased.  Figure 23 shows that Psub/Po 
was not significantly altered by a 2.6 fold increase in the trans chamber Cs+ 
concentration.  Increasing trans Cs+ from 250 mM to 650 mM produces a change in 
driving force equivalent to a 25 mV step increase in the negative potential across the 
bilayer. In the presence of 2 mM SAM and symmetrical 250 mM CsMS (250/250), Psub/ 
Po was 0.862 ± 0.034 and remained unchanged after raising the concentration of trans 
CsMs to 450 mM or 650 mM (0.802 ± 0.049 and 0.724 ± 0.071 respectively).  The 
finding that permeant cations do not interfere with SAM binding is inconsistent with the 
notion of a direct interaction of SAM with the ion permeation pathway.   
 
4.4.4. Voltage dependence of the subconductance state resides in the SAM off rate  
 SAM appears to interact with both the closed and open full conductance 
conformations of the RyR2 channel, because opening to the subconductance state occurs 
from both the closed and the open full conductance state (Fig. 15).  Because it is not 
possible to determine at what instant SAM binds the closed channel, kinetic analysis was 
limited to SAM’s interaction with the open channel.  This analysis was based on two 
assumptions i) dwell time of the subconductance state represents the residence time of 
SAM on the channel, and thus depends on the rate of SAM dissociation (koff), and ii) 
dwell time of the open full conductance state represents the unmodified state, and thus 
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depends on the rate of SAM association (kon).  Only transitions between the open full 
conductance and open subconductance levels were analyzed.  The remaining life times of 
the open full conductance and open subconductance states were well described by a 
single exponential.  The effect of voltage on SAM association and dissociation, shown in 
Figure 24, revealed that the voltage dependence of the substate resides in the off rate.  
The rate of SAM dissociation (koff) decreased from 0.581 ±10.148 ms-1at -75 mV to 
0.355 ± 0.045 ms-1 and 0.187 ± 0.046  ms-1at -50 and -25 mV, respectively.  Thus the 
increase in Psub/Po that occurred with decreasing negative potential results from a 
decrease in the rate of SAM dissociation.  The SAM association rate (kon) did not change 
with voltage (-75mV, 0.072 ±0.013 ms-1mM-1; -50 mV, 0.089 ±7.7 ×10-3 ms-1mM-1; -
25mv, 0.117 ± 0.012 ms-1mM-1).  Indeed, the subconductance openings were visibly 
prolonged as holding potential was made less negative.  Taking the ratio koff/ kon  yields a 
Kd of 1.6 mM, 4 mM, and 8 mM at -25, -50, and -75 mV, respectively.  SAM’s affinity 





Figure 23. Prevalence of the SAM related subconductance state is unaffected by a change 
in driving force for ion flux.  Single channel currents were recorded at a holding potential 
of -50 mV in 250 mM symmetrical Cs+ (250/250), and after increasing trans Cs+ to 450 
mM (250/450) and 650 mM (250/650).  Data points show means ± SEM of 5-7 









Figure 24.  Voltage dependence of the on and off rates for SAM binding RyR2.   Channel 
currents were recorded as described in Figure 21 in the presence of 2 mM SAM.  The rate 
of SAM association (on rate, kon ○) was unaffected by voltage while the rate of SAM 
dissociation (off rate, koff ●) decreased as holding potential was made less negative.  Data 
points show means ± SEM of 3-8 experiments.  Significantly different from -25 mV 









4.4.5. ATP interferes with the SAM induced subconductance state 
 The lack of effect of driving force on the prevalence of the SAM related substate 
argues against a pore block mechanism and suggests that SAM affects channel 
conductance by binding to a regulatory site located outside the conduction pathway.  
Adenine nucleotides compete with the SAM induced increase in CSR [3H]ryanodine 
binding; a strong indication that SAM and adenine nucleotides interact with a common 
regulatory site.  However, it was unclear whether an interaction between SAM and 
adenine nucleotides also occurred with respect to the SAM related substate.  
Representative data from experiments exploring competition between SAM and ATP are 
shown in Figure 25A.  Before SAM addition, the channel displayed flickery gating 
between the closed and the maximum full conductance state.  Following the addition of 2 
mM cis SAM the channel current fluctuated mainly between the closed state and the 
SAM related subconductance state.  The increased prevalence of the subconductance 
state in the presence of SAM is reflected in the amplitude histogram as a shift in current 
distribution to the subconductance level.  After subsequent addition of 10 mM cis ATP, 
the vast majority of openings were to the maximum full conductance level.  No 
adjustments in concentration of cis Ca2+ was made thus, chelation of free Ca2+ by ATP 
reduced overall channel Po in the presence of 10 mM ATP (Fig. 25 A).  The competition 
between ATP and SAM was evinced by a significant decrease in the prevalence of the 
SAM related substate.  Psub/Po decreased from 0.828 ± 0.011 in the presence of SAM 
alone to 0.500 ± 0.048 and 0.244 ± 0.286 following the addition of 5 mM and 10 mM 
ATP, respectively (Fig. 25B).  Furthermore, mean dwell time of the subconductance state 
decreased from 4.94 ± 0.785 ms in the presence of SAM alone to 2.74 ± 0.362 ms and 
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2.25 ± 0.192 following the addition of 5 and 10 mM ATP, respectively (Fig. 25C). In the 
presence of 2 mM cis SAM, openings to the full conductance level became very brief 
giving rise to the slight reduction in the amplitude of the maximum full conductance state 
in Figure 25 A (+ 2 mM SAM).  
 ATP was also able to partially reverse the SAM induced inhibition of RyR2 
observed at +50 mV.  In Figure 26A channel current fluctuations recorded at +50 mV, 
which were virtually abolished following the addition of 2 mM cis SAM, returned, 
although with lower frequency, upon the subsequent addition of 10 mM cis ATP.  
Summary data from 8 single channel recording experiments are presented in Figure 26B.  
Po, which was reduced from 0.448 ± 0.059 to 0.008 ± 0.002 following SAM addition, 
increased to 0.114 ± 0.023 with the subsequent addition of 10 mM ATP.   
 
4.4.6. The RyR2 agonist 4chloro-m-cresol (4-CmC) does not compete with SAM 
 A nonspecific agonistic effect on channel Po could be proposed to explain the 
ability of ATP to interfere with the SAM related substate at negative potentials, and the 
SAM induced inhibition at positive potentials.  4-Chloro-m-cresol (4-CmC) is a 
pharmacological agent which activates RyR with 10-25-fold higher potency compared 
with the commonly used channel activator, caffeine (148).  Representative data from 
experiments exploring competition between SAM and 4-CmC are shown in Figure 27A.  
Following the addition of 2 mM SAM, Psub/Po increased significantly from 0.264± 0.024 
to 0.843 ± 0.048 and remained elevated at 0.879 ± 0.027 upon subsequent addition of 0.6 
mM 4-CmC (Fig. 27 B).  An increase in the mean dwell time of the SAM related substate 
accounted for the effect of 4-CmC on Psub/Po (Fig. 27 C).  In 6 experiments competition 
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between 4-CmC and SAM was never observed.  Similarly, there was no competition 
between SAM and 4-CmC at a positive holding potential (+50 mV) (Fig. 28 A).  In all of 
7 experiments SAM caused significant channel inhibition reducing Po from 0.414 ± 0.113 
to 0.015 ± 0.007.  With the subsequent addition of 4-CmC, channel inhibition persisted 
(Po = 0.012 ± 0.006) (Fig. 28 B).  Thus, it is unlikely that the competition between SAM 
and ATP is due to a nonspecific agonistic effect of ATP, but rather the interaction of 






Figure 25.  ATP interferes with the SAM related subconductance state.  (A) Single 
channel currents shown as downward deflections from closed (c), were recorded as 
described in Figure 21at a holding potential of -50 mV.  The peaks in the amplitude 
histograms indicate the predominant conductance states of the channel. The current traces 
were obtained before (top) and after (middle) the addition of 2 mM cis SAM.  SAM 
induced a clearly defined subconductance state (s) which was largely abolished upon the 
subsequent addition of 10 mM ATP to the cis solution (bottom).  (B) Proportion of 
subconductance events for channels recorded as in A in the absence of SAM, following 
the addition of 2 mM SAM, and the subsequent addition of 5 mM ATP, and 10 mM ATP 
(C, S, S5A, and S10A respectively).  Data are shown as mean ± SEM for 4 experiments.  
Control vs. SAM *p<0.001, Control vs SAM + 5 mM ATP *p<0.05, #p<0.001, and  
SAM vs SAM + 10 mM ATP #p<0.001.  (C) Mean dwell times in the full open (black 
bars) and subconductance (white bars) state for channels recorded as in A in the absence 
of SAM, following the addition of 2 m SAM, and the subsequent addition of 5 mM ATP, 
and 10 mM ATP (C, S, S5A, and S10A respectively).  Data are shown as mean ± SEM 
for 4 experiments.  Control vs. SAM *p<0.01, control vs. SAM + 5 mM ATP *p< 0.05, 
control vs.  SAM +10 mM ATP * p<0.05, SAM vs. SAM + 5 mM ATP # p<0.05, and 
SAM vs. SAM + 10 mM ATP # p<0.05.  Mean open state dwell time were significantly 





Figure 26. Channel activity is partially restored by ATP following inhibition by SAM at 
positive holding potential.  (A) Single channel currents shown as upward deflections 
from closed (c), were recorded as described in Figure 21 at a holding potential of +50 
mV.  The peaks in the amplitude histograms indicate the predominant conductance states 
of the channel. Current fluctuations (top), which were nearly abolished immediately 
following the addition of 2 mM SAM to the cis solution (middle), were partially restored 
upon subsequent addition of 10 mM cis ATP (bottom).  (B) Open probability for 
channels recorded as in A in the absence of SAM (black bars), following the addition of 2 
mM SAM (white bars), and the subsequent addition of 10 mM ATP (grey bars).  Data are 
shown as mean ± SEM of 4 experiments.  Significantly different from control *p<0.001, 




Figure 27.  RyR2 agonist 4-chloro-m-cresol (4-CmC) does not interfere with the SAM 
related subconductance state. (A) Single channel currents shown as downward 
deflections from closed (c), were recorded as described in Figure 21 at a holding potential 
of -50mV.  The peaks in the amplitude histograms indicate the predominant conductance 
states of the channel. Following the addition of 2 mM cis SAM RyR2 current fluctuated 
predominantly between the closed (c) and subconductance (s) levels (middle traces), a 
pattern which persists upon subsequent addition of 0.6 mM cis 4-CmC.  (B) Proportion of 
subconductance events for channels recorded as in A in the absence of SAM, following 
the addition of 2mM SAM, and the subsequent addition of 0.6 mM 4-CmC (C, S, S + 4-
CmC respectively).  Data are shown as mean ± SEM for 6 experiments.  Significantly 
different from control *p<0.001.  (C) Mean dwell times in the full open (black bars) and 
subconductance (white bars) state for channels recorded as in A in the absence of SAM, 
following the addition of 2 mM SAM, and the subsequent addition of 0.6 mM 4-CmC (C, 
S, S + 4-CmC respectively).  Data are shown as mean ± SEM for 6 experiments.  
Significantly different from control *p<0.001, significantly different from SAM #p<0.01.  
Open dwell time was significantly increased over control in the presence of SAM plus or 





Figure 28.  RyR2 agonist 4-chloro-m-cresol (4-CmC) does not restore channel activity 
following inhibition by SAM at positive holding potential. (A) Single channel currents 
shown as upward deflections from closed (c), were recorded as described in Figure 21 at 
a holding potential of +50 mV.  The peaks in the amplitude histograms indicate the 
predominant conductance states of the channel. Current fluctuations (top traces), were 
nearly abolished immediately following the addition of 2 mM SAM to the cis solution 
(middle traces), and this SAM induced channel inhibition persisted upon the subsequent 
addition of 0.6 mM cis 4-CmC. (B) Open probability for channels recorded as in A in the 
absence of SAM (black bars), following the addition of 2 mM SAM (white bars), and 
subsequent addition of 0.6 mM 4-CmC (grey bars).  Data are shown as mean ± SEM for 




4.4.7. ATP does not interfere with the effects of an established RyR pore blocker 
 As an additional control we investigated whether ATP interferes with the TBA+ 
related substate.  Cytosolic tetra butyl ammonium (TBA+) produces a RyR2 substate 
(21% full conductance) at positive voltages via a pore block mechanism (86, 149).  In 
Figure 29 single channel currents recorded at +90mV showed a clearly resolvable low 
amplitude subconductance state in the presence of 0.5 mM cis TBA+.  Subsequent 
addition of 10 mM cis ATP did not decrease the prevalence of the TBA+ related substate.  
On average Psub/Po was 0.875 ± 0.066 and 0.912 ± 0.0271 in the presence of 0.5 mM 
TBA+ alone and 0.5 mM TBA+ plus 10 mM ATP, respectively (Fig. 29B).   The slight 
increase in Psub/Po caused by ATP was accompanied by a significant increase in mean 
dwell time of the TBA+ related substate analogous to the effect of 4-CmC on the SAM 
related substate (Fig. 27 C).  Therefore ATP does not interfere with the subconductance 
state produced by an established RyR2 pore blocker.  
 
4.4.8. ATP activation of RyR2 is not dependent on membrane potential 
 The lack of an effect of driving force on the prevalence of the SAM related 
substate and the specific ability of ATP to interfere with the SAM related substate argue 
for an allosteric mechanism, whereby SAM binding a regulatory site on the channel 
stabilizes a conformational state having reduced conductance.  The effects of SAM on 
RyR2 are voltage dependent, therefore if ATP and SAM bind a common regulatory site, 
ATP activation of RyR2 may also vary with membrane potential.  The effect of ATP on 
channel Po was monitored over a range of voltages from -100 to 100 mV.  The single 
channel current records in Figure 30A show that RyR2 activity was increased by 2 mM 
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ATP to a similar extent regardless of holding potential (Fig. 30 D).  Note the lack of an 
effect of ATP on channel conductance.  At -50 mV, Po was significantly increased from 
0.281 ± 0.093 to 0.699 ± 0.094 in the presence of 2 mM ATP, and was similarly 
increased at a holding potential of + 50 mV.  However, because of high variability among 
individual channels, these data did not reach significance (control, 0.447 ± 0.129; 2 mM 
ATP, 0.735 ± 0.084) (Fig. 30 B).  ATP increased mean open dwell time from 1.73 ± 
0.204 to 8.78 ± 3.01 ms at -50 mV, and from 2.0 ± 0.262 to 13.61 ± 5.808 ms at + 50 mV 







Figure 29. ATP does not interfere with the effects of a known pore blocker.  (A) Single 
channel currents shown as upward deflections from closed (c), were recorded as 
described in Figure 21 at a holding potential of +90 mV.  The peaks in the amplitude 
histograms indicate the predominant conductance states of the channel. The 
subconductance state (s) elicited upon the addition of 0.5mM cis TBA+ (middle traces) 
persists and is prolonged when 10 mM ATP is added to the cis solution (bottom traces).  
(B) Proportion of subconductance events for channels recorded as in A in the absence of 
TBA+, in the presence of 0.5 mM TBA+, and following the addition of 10 mM ATP (C, 
T, and T+A respectively).  Data are shown as mean ± SEM for 4 experiments.  
Significantly different from control *p<0.001.  (C) Mean full open state (black bars) and 
TBA+ induced subconductance state (white bars) dwell times for channels recorded as in 
A in the absence of TBA+, in the presence of 0.5 mM TBA+, and following the addition 
of 10 mM ATP (C, T, and T+A respectively).  Data are shown as means ± SEM for 4 
experiments and are expressed as relative to control to reduce affects of variability 
between individual channels.  Significantly different from TBA+ *p< 0.0.  Open dwell 






Figure 30. ATP activation of RyR2 is independent of voltage. (A) Single channel currents 
shown as downward or upward deflections from closed (c), were recorded as described in 
Figure 21 at ±50 mV.  (B) Open probability for channels recorded as in A in the absence 
(black bars), or presence of 2 mM ATP (white bars).  Data are shown as means ± SEM of 
6 experiments.  Significantly different from control *p<0.05.  (C) Mean open dwell time 
for channels recorded as  at  ±50 mV in the absence (black bars) or presence of 2 mM 
ATP (white bars).  Data are shown as means ± SEM of 6 experiments.  Significantly 
different from control *p<0.05. (D) The extent of RyR2 activation by ATP does not 
change with holding potential.  Open probability was analyzed as relative changes from 
control conditions (no ATP, -50 mV) induced by 2 mM ATP to reduce affects of 






4.4.9. Behavior of the SAM related substate is inconsistent with a gating scheme for 
open channel block 
 A final assessment investigated whether a reversible binding process provided a 
valid description of the SAM related substate. The model in Figure 31 A for reversible 
discrete block at a single site implies that the binding of SAM to a site in the conductance 
pathway of the open channel (O) gives rise to a subconductance form of the channel in 
complex with SAM (S•SAM).  Because dwell times in a given state are inversely 
proportional to the rate constants away from that state, a pore block model predicts that 
the dwell time of the open full conductance will be dependent on the SAM concentration 
while the dwell time of the subconductance state will be independent of SAM 
concentration. The mean dwell time of the open subconductance state was significantly 
increased in the presence of 2, 4, and 6 mM SAM.  However, because of high variability 
among individual channels, the data at 8 and 10 mM SAM did not reach significance.  In 
contrast, neither the mean dwell time of the open full conductance state or the closed state 
were affected by SAM.  These observations indicate that the one step blocking scheme in 






Figure 31.  Comparing a pore block and an allosteric model for the SAM related substate 
process. A) Simple blocking model which entails the binding of SAM to a single site on 
the open full conductance conformation, O, resulting in a subconductance form of the 
channel in complex with SAM, S SAM.  B) Allosteric model of subconductance state 
production by SAM which proposes that SAM preferentially binds to and stabilizes a 








Figure 32. Relationship between SAM concentrations and mean state dwell times.  
Relative Mean dwell times of the subconductance (●), maximum full conductance (○) 
and closed (▼) states as a function of SAM concentration for channels recoded as in 
Figure 21 at -50 mV.  Dose response curves show that duration of the subconductance 
state increased with increasing SAM concentration.  Durations of the maximum full 
conductance and closed state were independent of SAM concentration.  Data are shown 
as mean ± SEM from 2-3 experiments. * (substate), p<0.05 versus 0 mM SAM; # 









 We have previously reported that SAM directly activates RyR2 in a manner 
independent from its recognized role as a biological methyl group donor (146).  Several 
lines of evidence suggest that SAM and ATP share a common binding site. RyR2 
activation by SAM and ATP is similar in that both compounds enhance Ca2+ activation of 
the channel but have minimal effects on channel activity in the absence of Ca2+ and the 
dose response curves for SAM and ATP enhancement of CSR [3H]ryanodine binding 
virtually overlap.  Most convincingly, the adenine nucleotides ADP and AMP, which 
compete for ATP activation of RyR2, similarly compete with SAM activation of RyR2 in 
the presence of sub-activating, maximally-activating, and inhibitory Ca2+ concentrations. 
 Measurements of single channel activity revealed that SAM activation of RyR2 is 
associated with effects on channel conductance.  The effects of SAM on native RyR2 
channel conductance in symmetric 250 mM cesium methanesulfonate were dependent on 
SAM concentration and membrane holding potential.  SAM was effective in producing a 
single, clearly resolved subconductance state (~2/3 full conductance) only from the 
cytosolic side, and only at negative potentials which favor cis to trans Cs+ fluxes.  The 
subconductance state was voltage dependent, becoming less prevalent with higher 
negative potentials.    
 Two mechanisms vie to explain the effect of SAM on RyR2 conductance: i) SAM 
interferes directly with ion permeation via binding within the conduction pathway, or ii) 
the binding of SAM at a regulatory (or allosteric) site stabilizes or induces a reduced 
conductance conformation of the channel.  Evidence for entry of SAM into the 
conduction pathway of RyR2 was lacking.  Experiments investigated whether permeant 
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ions (Cs+) interfere with the SAM related substate. This approach has clarified the 
mechanism underlying ‘blocking’ phenomena in other ion channels. For example, 
Armstrong provided strong support for the notion that intracellular TEA+ blocks K+ 
channels through a direct interaction with the permeation pathway by showing that the 
TEA+ dissociation rate is increased by external K+ especially at membrane potentials that 
elicit inward K+ currents.  The SAM related substate was unchanged by a 2.6 fold 
increase in trans Cs+ concentration (change in driving force equivalent to a 25 mV step 
increase in the negative potential across the bilayer) (Fig. 25).  This lack of interference 
between permeant ions and the interaction of SAM with the channel is a strong indication 
that SAM affects channel conductance via a regulatory (allosteric) site on the cystolic 
face of the channel some distance from the ion conduction pathway.  
 Secondly, behavior of the SAM related substate was inconsistent with a reversible 
binding scheme. A simple two state model describing a reversible binding reaction is 
shown in Figure 34 A.  The significance of this model is that it is only realistic in the case 
of direct pore block (i.e. the physical interaction of the ‘blocking’ species with the 
permeation pathway). According to this scheme SAM binding to the open full 
conductance state (O) results in partial channel block which manifests as a 
subconductance state (S).  This mechanism predicts that the lifetime of the open state (O) 
will be inversely proportional to the rate of SAM binding, which in turn is dependent on 
the concentration of SAM, whereas lifetime of the subconductance state (S) is determined 
by the residence time of SAM at its site, a parameter which is independent of SAM 
concentration.  Thus, for the case of direct pore block, the lifetime of the open full 
conductance and subconductance states should be inversely proportional to and 
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independent of SAM concentration, respectively.  However, duration of the open full 
conductance state was unaffected by SAM concentration, whereas the duration of the 
subconductance state increased as a function of SAM concentration.     
 The state diagram in Figure 31 B is an allosteric model which accounts for, i) the 
interconversion between the closed (C), open (O), and subconductance (S) states, ii) the 
increased lifetime of the subconductance state with increasing SAM concentration, iii) 
the voltage dependent behavior of the SAM related subconductance state at negative 
potentials, and iv) the competition between ATP and SAM.   It was clear from single 
channel current recordings that RyR2 can enter the subconductance state (S) from either 
the open full conductance state (O) or the closed state (C), hence the triangular scheme 
which allows for interconversion between all three states.  Although conductance levels 
are shown as single states (O, S, C) in the diagram, this is not meant to imply a direct 
correspondence between channel conductance and channel state (or conformation).  In 
other words RyR2 may adopt multiple distinct conformations which can not be 
distinguished based on conductance alone.   
 SAM does not appear to induce the change in channel conformation (to the 
subconductance conformation).  Rather, SAM binds to and stabilizes an inherent 
subconductance conformation.  When bound by SAM (S•SAM) the subconductance 
conformation is more energetically favorable (stable). Support for this interpretation is 
based upon the presence of brief infrequent openings to the subconductance state even in 
the absence of SAM which increase in duration as a function of SAM concentration.   
 The scheme depicted in Figure 31 B, attributes the apparent voltage dependence 
of SAM’s interaction (increase in koff with increasing negative potentials) to a voltage 
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dependent (*) equilibrium between at least two inherent channel conformations (the open 
full conductance state (O) and the subconductance state (S)).  By this allosteric 
mechanism, voltage indirectly influences SAM binding.  The regulatory site has a high 
affinity for SAM when the channel is in the S conformation and a low affinity for SAM 
when the channel is in the O conformation.  Higher negative potentials shift the 
equilibrium towards the O conformation giving rise to the apparent increase in koff as 
voltage becomes more negative.  Due to the brevity and low frequency of 
subconductance openings in the absence of SAM it was not possible to directly 
investigate the voltage dependence of the substate in the absence of SAM.   
 The proposed allosteric model also addresses the competitive effects of SAM and 
ATP on RyR2 activity.  Measurements of [3H]ryanodine binding showed that the 
characteristics of SAM and ATP activation of RyR2 both involve an enhancement of 
Ca2+ activation of the channel, and the dose response curves virtually overlapped.  The 
adenine nucleotides, ADP and AMP, which competed for ATP activation of RyR2, 
similarly competed for SAM activation of the channel.   At the single channel level 
competition was observed as an interference of ATP with the SAM related 
subconductance state.  This was a specific competition between ATP and SAM.  The 
RyR2 agonist 4-CMC did not interfere with the SAM related subconductance state.   The 
competition between SAM and ATP can be attributed to the existence of a regulatory site 
to which either SAM or ATP can bind.  Presumably this regulatory site is specific for 
adenine nucleotides, and SAM and ATP interact with this site via their common 
structural feature, the adenosine moiety.  Others have shown that concentrations of ATP 
≤ EC50 primarily increased channel Po by increasing the frequency of channel openings 
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while [ATP] ≥ EC50 progressively increased Po by increasing the duration of channel 
openings (43).  Thus, ATP is shown interacting with the open full conductance state (O) 
and the closed state (C).  The lack of effect of membrane potential on ATP activation 
(Fig. 30) indicates that ATP is unable to bind its regulatory site when the channel is in the 
S conformation.   
Within the limits of an allosteric model involving SAM binding the adenine 
nucleotide binding site, one of two possibilities may explain the voltage dependent effect 
of SAM.  The first possibility purports the existence of a subconductance state which 
interconverts in a voltage dependent manner with the open full conductance state.  
Although indirect, support for this interpretation comes from the observation that a 
clearly defined subconductance state is observed with low frequency in channel currents 
recorded in the absence of SAM.  Alternatively, the adenine nucleotide binding site lies 
within the membrane electric field.  However support for this interpretation is lacking as 
ATP activation of RyR2 was not dependent on membrane holding potential.   In 
summary, the effects of SAM and ATP are mediated through a common binding site and 
a direct effect of voltage on protein conformation accounts for the voltage dependent 
effects of SAM.  This work underscores the complexity of ion channel gating and its 
modulation; it affirms the notion that channels exist in manifold conformations with 




PERSPECTIVE AND FUTURE DIRECTIONS 
 
5.1. Summary of presented work 
 The goal of this dissertation was to clarify the mechanism by which SAM 
regulates RyR2.  Initial experiments aimed at characterizing the effect of SAM on RyR2 
employed [3H]ryanodine binding to cardiac SR vesicles.  CSR vesicle [3H]ryanodine 
binding was increased by SAM at  concentrations as low as 75 μM.   The Ca2+ 
concentration dependence of CSR [3H]ryanodine binding revealed that SAM activation of 
RyR2 is Ca2+ dependent; SAM increased Ca2+ activation of the channel, but alone did not 
activate.  Saturation analysis indicated that low concentrations of SAM primarily 
enhanced CSR [3H]ryanodine binding by increasing the affinity of RyR2 for ryanodine, 
while higher concentrations of SAM also increased the number of channels which bind 
ryanodine.  Additional experiments investigated the effects of SAM on RyR2 in the 
presence of other physiological RyR2 effectors.  Alone SAM and the nonhydrolysable 
ATP analogue AMPPNP enhanced CSR [3H]ryanodine binding however, combined their 
effects were not additive.  This was an early indication of an interaction between SAM 
and ATP.  
 Because SAM is well-known for its role as a biological methyl group donor I 
explored whether methylation mediated the effect of SAM on RyR2 activity.  SAH and 
sinefungin are methyltransferase inhibitors; SAH works by mass action while sinefungin 
competes with the SAM binding site on the enzyme.  Neither SAH nor sinefungin 
interfered with the SAM induced increase in CSR [3H]ryanodine binding.  The 
 137
incorporation of methyl groups into CSR incubated with a radiolabeled SAM (S-
adenosyl-L-[methyl-3H]-methionine) was investigated. Scintillation counts (radioactivity) 
remained elevated after multiple wash steps indicating methylation of some CSR 
component(s).  However, imunoprecipitation showed that no amount of the radioactivity 
was specifically associated with RyR2.  This was direct evidence that RyR2 was not 
methylated in the presence of SAM, and that methyltransferase activity was not required 
for SAM activation of RyR2.  
 With confidence that SAM activation of RyR2 is independent from its function as 
a methyl group donor, interest shifted to the structural similarity between SAM and ATP.  
Several lines of evidence suggested that SAM and ATP share a common binding site.  
RyR2 activation by SAM and ATP was similar in that both compounds enhance the Ca2+ 
activation of the channel but have minimal effects on channel activity in the absence of 
Ca2+ and the dose response curves for SAM and ATP enhancement of CSR 
[3H]ryanodine binding virtually overlapped.  Most convincingly, the adenine nucleotides 
ADP and AMP, which competed for ATP activation of RyR2, similarly competed with 
SAM activation of RyR2 in the presence of sub-activating, maximally-activating, and 
inhibitory Ca2+ concentrations.  
 At the single channel level, 100 μM cytosolic SAM increased RyR2 Po, consistent 
with results from CSR [3H]ryanodine binding.  The aim to compare the kinetics of SAM 
and ATP activation of RyR2 was encumbered by the unexpected observation that SAM 
promoted a subconductance state having an amplitude ~ 2/3 of the open full conductance 
level.  The subconductance state was SAM concentration dependent, accounting for 
almost 60% of the overall channel Po in the presence of 2 mM SAM.  Cytosolic SAM did 
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not affect the open full conductance level and luminal SAM had no effect on channel 
activity.   
 SAM has a net positive charge and a molecular weight close to that of the charged 
local anesthetic lidocaine, and two quaternary amines (QX572 and QX314) which affect 
RyR2 conductance via a direct interaction with the permeation pathway (i.e. pore block).  
However, the SAM related substate process was incompatible with the hypothesis that 
SAM affects channel conductance via pore block.  Firstly, premeant cations did not 
appear to interfere with SAM binding as the prevalence of the SAM related 
subconductance state was unaffected by a change in the driving force for ion flux.  This 
lack of interference between permeant cations and the interaction of SAM with the 
channel was a strong indication that SAM affects channel conductance via a regulatory 
(allosteric) site on the cytosolic face of the channel some distance from the ion 
conduction pathway.  Further analysis revealed that the duration of the subconductance 
state increased as a function of SAM concentration.  This behavior is consistent with the 
notion that SAM binds to and stabilizes an inherent RyR2 subconductance conformation.     
 The kinetics of SAM and ATP activation could not be compared as originally 
planned due to the confounding effect of SAM on RyR2 conductance.  Both SAM and 
ATP increased channel Po, however only SAM induced a subconductance state, thus the 
SAM related substate could be used as gauge for determining whether SAM and ATP 
bind a common regulatory site on the channel.  ATP caused a decrease in the prevalence 
of the SAM related subconductance state.  This competition was dose dependent (10 mM 
ATP more effective than 5 mM ATP) and specific to ATP.  The RyR2 agonist 4-CmC 
did not interfere with the SAM related subconductance state.  Furthermore, ATP did not 
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interact with the effects of a known RyR2 pore blocker, TBA+.  Together these data 
suggested that SAM and ATP share a common binding site.     
 In summary, SAM is a RyR2 channel agonist which induces a subconductance 
state.  This work indicates that SAM modulates RyR2 channel gating through a direct 
physical interaction with a site located on the cytosolic face of the channel, and that SAM 
and ATP share a common binding site.  Unlike ATP, the interaction of SAM with RyR2 
is voltage dependent.  I have proposed an allosteric model whereby voltage driven 
changes in channel conformation alter the affinity of a putative regulatory site (possibly 
the adenine nucleotide site) for SAM.  By this mechanism, the direct effect of voltage on 
protein conformation gives rise to the voltage dependent subconductance behavior 
produced by SAM.   
 
5.2. Future direction and implications 
 A working model for SAM regulation of RyR must first consider the mode of 
interaction.  SAM is an established methyl group donor and SAM mediated methylation 
of RyR2 would be a novel mechanism of RyR2 channel regulation with potential 
implications for the physiological and pathological control of cardiac function.  However, 
this work showed that SAM regulation of RyR2 does not involve methylation.  
Methyltransferase inhibitors did not block SAM activation of RyR2 and methylation of 
the channel was not detected.  Furthermore, if SAM regulated RyR2 via methylation a 
delayed effect would be expected.  However, direct measurements of channel activity 
showed that the effects of SAM are immediate and independent of exposure time to 
SAM.  These findings establish SAM as a novel RyR2 regulatory ligand.   
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 Direct measurements of RyR2 channel activity revealed a SAM related 
subconductance state.  Initial speculation that SAM binding causes the dissociation of a 
RyR2 regulatory protein was based on apparent irreversibility of the subconductance 
state (146).  In repeated single channel experiments, an increased proportion of 
subconductance events were detected under control conditions if the bilayer apparatus 
was not thoroughly washed at the end of the preceding experiment (personal 
observation). Efficient removal of SAM from even the single channel recording apparatus 
appears to require very thorough washing.  Thus in retrospect, I attribute the relatively 
high proportion of subconductance events in SAM pretreated channels (146) to 
incomplete removal of SAM from the CSR.  
 Two remaining mechanisms vied to explain the SAM related subconductance 
state.  The pore block mechanism attributes the effect of SAM on RyR2 conductance to a 
direct interference with ion permeation via SAM binding within the conduction pathway.  
The alternative allosteric mechanism envisions the binding of SAM to a regulatory (or 
allosteric) site stabilizes or induces a reduced conductance conformation of the channel.   
 Findings from this research make a pore block mechanism for the effect of SAM 
of RyR2 conductance improbable.  The interference between permeant ions and the SAM 
related substate was investigated. This approach has clarified the mechanism underlying 
‘blocking’ phenomena in other ion channels. For example, Armstrong provided strong 
support for notion that intracellular TEA+ blocks K+ channels by binding a site located in 
the permeation pathway by showing that the TEA+ dissociation rate is increased by 
external K+ especially at membrane potentials that elicit inward K+ currents (97). The 
prevalence of the SAM related subconductance state was unchanged when the driving 
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force for cation (Cs+) flux was increased under asymmetric conditions (elevated trans 
Cs+).  Therefore, permeant ions did not appear to interfere with SAM reaching its binding 
site on the channel.  Additionally, behavior of the SAM related substate was inconsistent 
with a simple reversible binding scheme for open channel block.  According to the model 
in Figure 33, SAM binds in or very near the conduction pathway producing a 
subconductance state (S) by direct interference with ion permeation (either by physical 
occlusion or electrostatic repulsion).  This reversible binding scheme predicts the 
duration of the open full conductance state to be inversely proportional to SAM 
concentration.  However, mean dwell time of the open full conductance state was not 
dependent on SAM concentration.  Rather, the mean dwell time of the subconductance 
state increased with SAM concentration.  Therefore I conclude that SAM does not 
directly interact with the permeation pathway of the channel.  I propose that the 
subconductance state represents a channel conformation with altered permeation 
properties, which becomes more energetically favorable when bound by SAM. 
 The state diagram in Figure 34 is a summary of the experimental findings.  It is 
clear from single channel current recordings that RyR2 can enter the subconductance 
state (S) from either the open full conductance state (O) or the closed state (C), hence the 
triangular scheme (in black) which allows for interconversion between all three states.  
Although conductance levels are shown as single states (O, S, C) in the diagram, this is 
not meant to imply a direct correspondence between channel conductance and channel 
state (or conformation).  In other words RyR2 may adopt multiple distinct conformations 
which can not be distinguished based on conductance alone.   
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 SAM does not appear to induce the change in channel conformation (to the 
subconductance conformation).  Rather, SAM binds to and stabilizes an inherent 
subconductance conformation (shown in blue).  When bound by SAM (S•SAM) the 
subconductance conformation is more energetically favorable (stable). Support for this 
interpretation is based upon the presence of brief infrequent openings to the 
subconductance state even in the absence of SAM which increased in duration as a 
function of SAM concentration.   
 SAM only effectively produced the subconductance state from the cytosolic face 
of RyR2, and only at negative holding potentials which favor luminal to cytosolic cation 
fluxes.  The substate became less prevalent with higher negative potentials.  A voltage 
dependent (V) equilibrium between at least two inherent channel conformations (the open 
full conductance state (O) and the subconductance state (S) in Figure 34 can account for 
the apparent voltage dependence of SAM’s interaction (kon and koff).  I propose that the 
regulatory site has a high affinity for SAM when the channel is in the S conformation and 
a low affinity for SAM when the channel is in the O conformation.  Higher negative 
potentials shift the equilibrium towards the O conformation giving rise to the apparent 





Figure 33. Predictions based upon a pore block mechanism for the SAM related 
subconductance state.  The gating scheme for open channel block predicts the duration of 
the open full conductance state (O) will decrease as the concentration of SAM in 
increased, while the duration of the SAM bound subconductance state (S•SAM) will be 







Figure 34. Allosteric model of the SAM related subconductance state.  SAM binds to and 
stabilizes and inherent subconductance state (S).  The model proposes a voltage 
dependent (V) equilibrium between the open full conductance (O) and inherent 
subconductance state (S) to account for the voltage dependence of SAM’s interaction 
with the channel.  SAM and ATP bind a common regulatory site; SAM has a high 
affinity for this site when the channel is in the S conformation while ATP has a high 
affinity for this site when the channel is in the O conformation.  SAM inhibition 
(C*•SAM; inactivated state) of RyR2 at positive potentials could be accommodated in 
our model by postulating a pathway whereby positive voltages promote one or more 




 My model also addresses the competitive effects of SAM and ATP on RyR2 
activity.  Measurements of [3H]ryanodine binding showed that the characteristics of SAM 
and ATP activation of RyR2 both involved an enhancement of Ca2+ activation of the 
channel, and the dose response curves virtually overlapped.  The adenine nucleotides, 
ADP and AMP, which competed for ATP activation of RyR2, similarly competed for 
SAM activation of the channel.   At the single channel level competition was observed as 
an interference of ATP with the SAM related subconductance state.  This was a specific 
competition between ATP and SAM.  The RyR2 agonist 4-CmC did not interfere with 
the SAM related subconductance state.   I attribute the competitive effects of SAM and 
ATP to the existence of a regulatory site to which either SAM or ATP can bind.  
Presumably this regulatory site is specific for adenine nucleotides; SAM and ATP 
interact with this site via their common structural feature, the adenosine moiety.  Others 
have shown that concentrations of ATP ≤ EC50 primarily increased channel Po by 
increasing the frequency of channel openings while [ATP] ≥ EC50 progressively 
increased Po by increasing the duration of channel openings (43).  Thus, ATP is shown 
interacting with the open full conductance state (O) and the closed (C) (Fig.34, green).  
The lack of effect of membrane potential on ATP activation indicated that ATP is unable 
to bind its regulatory site when the channel is in the S conformation.  ATP activation of 
RyR2 was not voltage dependent and ATP did not produce a subconductance state.  
Although perplexing, these observations are not irreconcilable with our allosteric model. 
My model suggests that ATP, by stabilizing the full open state of the channel, reduces the 
availability of the high SAM affinity S state.  
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 In summary, the effects of SAM and ATP are mediated through a common 
binding site and a direct effect of voltage on protein conformation accounts for the 
voltage dependent effect of SAM.  This work underscores the complexity of ion channel 
gating and its modulation; it affirms the notion that channels exist in manifold 
conformations with distinct ion permeation properties. 
 Questions remain regarding the inhibitory effect of SAM on RyR2 at positive 
potentials. Channel activity was virtually abolished in the presence of 2 mM cytosolic 
SAM.  SAM ‘inactivation’ (C*•SAM; inactivated state) of RyR2 at positive potentials 
could be accommodated in the model by postulating a mechanism whereby positive 
voltages impose different forces on the channel protein giving rise to one or more  
different channel conformations (X) which lead into a distinct gating pathway (Fig. 34, 
dotted arrows).  Importantly, competition between SAM and ATP was also observed at 
positive potentials suggesting that SAM ‘inactivation’ of RyR2 is likewise mediated via a 
regulatory site shared by ATP.  Due to channel inactivation, the interaction of SAM with 
RyR2 at positive potentials was not amenable to kinetic analysis.  However, by ‘locking’ 
the channel open with ryanodine it may be possible to analyze the interaction of SAM 
with ryanodine-modified RyR2 at positive potentials in spite of SAMs strong inhibitory 
effect. This approach was used to investigate the interaction of ruthenium red with RyR1 
(100).  In the presence of 0.3 mM SAM, channel Po was reduced by approximately 50% 
compared to the over 90% reduction in Po observed in the presence of 2 mM SAM.  It 
may therefore be possible to gain insight into the interaction of SAM with RyR2 at 
positive potentials by analyzing channel activity in the presence of micromolar SAM 
concentrations which promote only a moderate reduction in channel activity.         
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 As this work has demonstrated, direct measurements of channel activity can 
provide insights that might not be detected by ryanodine binding measurements.  There 
are some discrepancies between the effects of SAM on RyR2 revealed from ryanodine 
binding measurements and single channel recordings.  Ryanodine binding did not saturate 
with up to 10 mM SAM, however channel Po reached a plateau at ~2 mM SAM.  
Although there is evidence to suggest that the high affinity ryanodine binding site is 
available only when the channel is open (27, 28, 92), more recent findings indicate that 
ryanodine does not bind within the channel pore (89, 93, 150).  Therefore, although 
measurements of ryanodine binding correlate reasonably well with RyR activation levels, 
it is not surprising to find equilibrium ryanodine binding measurements are not a direct 
reflection of channel open time.  One can reconcile the inhibitory effect of SAM 
observed in direct measurements of RyR2 activity at positive potentials with the SAM 
induced increase in CSR ryanodine binding by the fact that a transmembrane potential of 
0 mV is expected during ryanodine binding measurements.    
 SR membrane is highly permeable to monovalent cations and anions suggesting 
that the potential across the SR in resting muscle is close to 0 mV (151).  The question 
arises as to whether SAM produces a subconductance state when transmembrane 
potential is held at 0 mV.  This investigation may be informative. The disparate effects of 
SAM on RyR2 activity at positive and negative potentials demonstrated that SAM 
interacts with RyR2 in a voltage dependent manner.  Therefore at 0 mV holding potential 
I would expect SAM regulation of RyR2 to differ from the effects described in this work.   
 Both cardiac and skeletal RyRs (RyR2 and RyR1, respectively) are activated by 
millimolar concentrations of adenine nucleotides; however the activation characteristics 
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of the two isoforms have a number of important differences.  A major difference is that 
adenine nucleotides activate RyR1in the absence of Ca2+ (43, 152, 153), while RyR2 
requires Ca2+ for adenine nucleotide activation (43, 61).  A similar discrepancy in the 
requirement of Ca2+ for SAM activation of the RyR1 and RyR2 would provide additional 
evidence that SAM binds ATP sites on the channel.    
 Adenosine antagonizes ATP activation of both RyR1 and RyR2 by a mechanism 
in which adenosine is a relatively weak agonist that competes for ATP binding sites on 
the channel (43, 61, 153).  However, adenosine is noted to be a weaker activator of RyR1 
compared to RyR2 (61, 153).  Furthermore, the relative affinities for ATP and adenosine 
are quite different in RyR2 and RyR1; in RyR1, the ratio of the dissociation constants 
KATP/Kadenosine is ~ 6, while in RyR2 KATP/Kadenosine is ~1 (153).  Thus adenosine is a more 
potent inhibitor of ATP activation of RyR1 compared to RyR2.  A comparison of the 
effect of adenosine on SAM activation of RyR1 and RyR2 would be informative.  Based 
on the hypothesis that SAM and ATP share a common binding site I expect adenosine to 
more effectively antagonize SAM activation of RyR1. 
 Although our data suggest SAM and ATP share a common binding site we can 
not rule out the possibility that these two molecules interact with distinct sites which are 
allosterically coupled.  Sequence analysis of RyR1 predicts at least eight adenine 
nucleotide consensus binding motifs per monomer (69) however, the characteristics of 
RyR activation by ATP, and direct binding studies suggest the presence of only two ATP 
binding sites per RyR monomer (43, 63).   Mutagenesis of two predicted ATP binding 
sequences, GXGXXG (amino acids 2370-2375 of RyR1), and YSGK (amino acids 3937-
3940 of RyR1), which are conserved among all RyR isoforms, did not alter the ATP 
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induced increase in [3H]ryanodine binding to any of the RyR1 mutants (69).  Thus far the 
combined use of functional assays and molecular biology has not identified which, if any, 
of the predicted consensus motifs confers sensitivity of RyR to ATP.  Although low 
resolution reconstructions of RyR have been obtained (154), high resolution 
crystallographic means will be required to confidently locate ATP binding sites by 
structural means. 
 An important question concerns the significance of SAM regulation of RyR2.  
Our findings indicate that SAM and ATP regulate RyR2 via a common binding site.  The 
overlap of the SAM and ATP dose-response curves indicates the regulatory site has 
similar affinity for these two molecules.  Therefore, SAM regulation of RyR2 is unlikely 
of physiological relevance given that cytosolic levels of ATP in cardiac cells (5-6 mM) 
(58) far exceed cellular concentrations of SAM (60-90 μM) (112).  However, the notion 
that SAM regulates RyR2 via adenine nucleotide regulatory sites has important 
implications for clarifying the structural basis of ATP regulation of the channel and 
provides insight into the molecular characteristics (i.e. steric factors, charge distribution) 
required of ligands acting through the adenine nucleotide regulatory sites.  Furthermore, 
study of the SAM related subconductance state provides insight into mechanisms of 
RyR2 gating.  The finding that SAM stabilizes a subconductance conformation of RyR2 
suggests substates may be an inherent characteristic of RyR channel gating.    
 
4.3. Closing   
 RyR2 plays a critical role in the contractile performance of the heart and recent 
compelling evidence positions RyR2 as a potential target for the treatment of cardiac 
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arrhythmias and heart disease.  However, uncertainty remains regarding the structural 
motifs involved in RyR2 modulation by even its principal physiological ligands, Ca2+ and 
ATP.  Therefore, the interaction of SAM with the ATP regulatory site(s) is a novel 
finding which has exciting implications for clarifying the structure-activity relationship 
underlying ATP regulation of RyR2. The SAM related subconductance state is of special 
interest because it appears to involve an allosteric mechanism of gating modification.  
Patterns in the transitions between RyR2 conductance states in the presence of SAM may 
provide insight into the structure-activity relationship of RyR2 which can aid in the 
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